Chronic pain following inguinal hernia repair by Page, Blaithin
 Glasgow Theses Service 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk 
 
 
 
 
 
Page, Blaithin (2009) Chronic pain following inguinal hernia repair.  
MD thesis. 
 
 
 
 
 
http://theses.gla.ac.uk/2579/ 
 
 
 
Copyright and moral rights for this thesis are retained by the author 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author 
 
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
 
 CHRONIC PAIN FOLLOWING INGUINAL HERNIA REPAIR 
 
 
 
                                        Miss Blaithin Page,  
                    B.Sc. (Honours), M.B.Ch.B., F.R.C.S (Glasgow). 
 
         Thesis submitted for degree of M.D. at University of Glasgow. 
 
Research conducted at Department of Surgery, Western General Infirmary,  
                                          Glasgow, Scotland. 
  
                                   Thesis submitted June 2009.    
 
Table of Contents 
Table of Contents................................................................................................................. i 
List of Tables ..................................................................................................................... iii 
Abstract ................................................................................................................................v 
Publications arising from the thesis ................................................................................... ix 
List of symbols, abbreviations and nomenclature.............................................................. xi 
Statement of collaboration ................................................................................................ xii 
Acknowledgements.......................................................................................................... xiii 
CHAPTER 1:  REVIEW OF LITERATURE ...................................................................1 
1.1. Introduction...............................................................................................................2 
1.2. Definition of pain; what is chronic pain?..................................................................2 
1.3. Pathophysiology of chronic pain ..............................................................................4 
1.4. The economic burden of chronic pain ......................................................................7 
1.5. The prevalence of chronic pain.................................................................................9 
1.6. Race and ethnic influences on chronic pain............................................................14 
1.7. Age and sex influences on chronic pain .................................................................16 
1.8. Psychology and its influence on chronic pain ........................................................19 
1.9. How to measure pain ..............................................................................................21 
1.10. Chronic pain in relation to surgery .......................................................................30 
1.11. Chronic pain and inguinal hernia repair ...............................................................35 
1.12. Preoperative factors that may contribute to post herniorrhaphy chronic pain......40 
1.13. Anatomy and physiology of the inguinal canal ....................................................41 
1.14. Intraoperative factors that may contribute to post herniorrhaphy chronic pain....45 
1.15. Characteristics of mesh types ...............................................................................49 
1.16. Laparoscopic hernia repair and chronic pain........................................................52 
1.17. Postoperative factors that may influence post herniorrhaphy chronic pain..........54 
    1.18 Current treatment options for those with post herniorrhaphy pain………………55 
CHAPTER 2:  AIMS.......................................................................................................59 
CHAPTER 3:  OUTCOME OF PATIENTS WITH SEVERE CHRONIC PAIN 
FOLLOWING REPAIR OF A GROIN HERNIA....................................................60 
3.1.  Introduction............................................................................................................61 
3.2.  Patients and Methods .............................................................................................61 
3.3. Statistical analysis...................................................................................................64 
3.4.  Results....................................................................................................................64 
3.4.1.  Effects on daily activities and quality of life ..........................................65 
3.4.2.  Character of pain and numbness .............................................................65 
3.4.3.  Other chronic pain conditions .................................................................66 
CHAPTER 4:  PAIN FROM A PRIMARY INGUINAL HERNIA AND THE 
EFFECT OF REPAIR ON PAIN..............................................................................71 
4.1.  Introduction............................................................................................................72 
4.2.  Patients and Methods .............................................................................................72 
4.3.  Statistical analysis..................................................................................................73 
 i
4.4.  Results....................................................................................................................73 
CHAPTER 5:  IMPACT OF PARTIALLY ABSORBABLE OR NON 
ABSORBABLE MESH ON CHRONIC PAIN AFTER INGUINAL HERNIA 
REPAIR. 79 
5.1.  Introduction............................................................................................................80 
5.2.  Patients and Methods .............................................................................................80 
5.3.  Mesh types .............................................................................................................81 
5.4.  Statistical analysis..................................................................................................84 
5.5.  Results....................................................................................................................85 
5.5.1.  Pain at 12 months post hernia repair.......................................................86 
5.5.2.  Clinical outcome at 12 months................................................................86 
CHAPTER 6:  DISCUSSION .........................................................................................94 
Summary of findings of the three trials. ........................................................................95 
6.1.1.  Trial 1......................................................................................................95 
6.1.2.  Trial 2......................................................................................................95 
6.1.3.  Trial 3......................................................................................................95 
Significance of findings .................................................................................................96 
Current treatment options for those with post herniorrhaphy pain.Error! Bookmark not defined. 
Further research ...........................................................................................................104 
APPENDIX 1...................................................................................................................108 
QUESTIONNAIRE (MODIFICATION OF SF36 )........................................................108 
APPENDIX 2...................................................................................................................111 
QUESTIONNAIRE (BPI ) AND ABOVE......................................................................111 
APPENDIX 3...................................................................................................................114 
(VISUAL ANALOGUE PAIN SCALES).......................................................................114 
APPENDIX 4...................................................................................................................115 
VISIT 1 ............................................................................................................................123 
 
 ii
List of Tables 
Table 1.1. Predictive factors for chronic pain as per Perkins 122. .....................................33 
Table 1.2. Results from chronic pain studies that used detailed questionnaires...............39 
Table 1.3. Textile properties of mesh materials................................................................51 
Table 3.1. Flow diagram of patients for Study 1. .............................................................63 
Table 3.4.1. Details of patients, hernia and operation type and grade of surgeon 
performing the operation who completed the second questionnaire.........................67 
Table 3.4.2 Effect on daily activities and quality of life values, given as mean (95% 
confidence interval). * One patient did not complete this section. ...........................68 
Table 3.4.3 Descriptors of pain. * One patient did not complete this section. .................69 
Table 3.4.4 Numbness (p< 0.001). * One patient did not complete this section. .............70 
Table 3.4.5 Other chronic illnesses (p=0.016). * Two patients did not complete this 
section. ......................................................................................................................70 
Table 4.4.1. Patient characteristics. Values in parentheses are percentages.....................75 
Table 4.4.2. Severity of pain in 323 patients. Data given is, number of patients (% of 
total). .........................................................................................................................76 
Table 4.4.3. Pain scores in relation to patient characteristics. Values are mean (s.d). .....77 
Table 4.4.4. Severity of pain 1 year after hernia repair in 204 patients. Data given is 
number of patients (% of total). ................................................................................78 
Table 4.4.5. Effect of operation on postoperative pain score. Values are mean 
(s.e.m.). .....................................................................................................................78 
Table 5.5.1. Patient and hernia characteristics..................................................................88 
Table 5.5.2. Anaesthetic and operative details, * values are mean (s.d). .........................89 
Table 5.5.3. Pain at 1 and 3 months..................................................................................90 
Table 5.5.4. Visual Analogue Pain Scores (VAS) at 1 and 3 months. The statistical 
test used was the Mann-Whitney U *. ......................................................................91 
Table 5.5.5. Return to normal activities. Values given are medians (inter-quartile 
range). .......................................................................................................................92 
Table 5.5.6. Clinical outcome at 12 months. Analysis was performed on ITT 
population, n=162 for PA and n=159 for NA. ..........................................................93 
 iii
List of Figures and Illustrations 
Figure 1.1. Melzack’s gate theory of pain 44.....................................................................13 
Figure 1.2. McGill pain questionnaire. .............................................................................26 
Figure 1.3. Multidimensional (West-Haven-Yale) pain inventory or brief pain 
inventory 100. .............................................................................................................27 
Figure 1.4.  Visual analogue pain scale. ...........................................................................28 
Figure 1.5. Faces pain scale. .............................................................................................28 
Figure 1.6. The pre-peritoneal pelvic anatomy with the iliopsoas fascia partially 
excised to expose the femoral nerve on the right side. .............................................43 
Figure 1.7. Position of the nerves from the anterior approach in the right inguinal 
canal. .........................................................................................................................44 
Figure 4.1. PA Vipro 11 mesh ..........................................................................................82 
Figure 4.2. NA Prolene (Atrium) mesh ............................................................................83 
  
 iv
Abstract 
 
Introduction 
In the past five years chronic post herniorrhaphy pain has become the predominant post 
operative complication following the common procedure of inguinal hernia repair. 
However information regarding the precise aetiological factors of this chronic post 
surgical pain is lacking. To date no previous studies have assessed the long term outcome 
of patients who report chronic severe pain following inguinal hernia surgery. There are 
no studies assessing the presence of preoperative pain and the effect of surgical 
intervention on these pain scores. One factor thought to contribute to post herniorrhaphy 
chronic pain is the mesh type used by the surgeon. The characteristics of two different 
mesh types are evaluated with respect to postoperative chronic pain. 
 
Aims 
The aim of the first study was to assess the outcome of patients who report severe or very 
severe pain three months after groin hernia repair.  
The aim of the second study was to quantify patients’ pain from their inguinal hernia 
prior to surgery and to examine the effect of surgery on this pain.  
The aim of the third study was to compare the composite partially absorbable and 
ultimately lighter weight (Vypro 11) mesh with an example of a conventional 
polyprolene mesh (Atrium) in a tension free repair of an inguinal hernia.  
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Methods 
One hundred and twenty five patients were identified as experiencing severe chronic pain 
at 3 months post herniorrhaphy, from the prospective National Hernia database1  of 5506 
patients (97% of total) between 1 April 1998 and 31 march 1999.  These 125 patients 
were assessed at 30 months post-surgery, with the use of the modified SF36 quality of 
life questionnaire.  
For the second study, consecutive patients referred for elective inguinal hernia repair 
between January 1998 and October 2000 completed visual analogue pain scores (VAS) 
pre- and 1 year post-repair. These patients were Western Infirmary patients who were 
part of a larger multicenter clinical trial comparing local versus general anaesthesia 2 for 
inguinal hernia repair.  
The third study examined patients who were involved in a multicenter trial comparing 
the incidence and severity of chronic pain following elective inguinal hernia repair, 
comparing the light weight or partially absorbable (PA) to the standard heavy weight or 
non-absorbable (NA) mesh.  
 
Results 
In the first study, of the 125 patients who experienced severe chronic pain at three 
months post repair, at 30 months post-surgery 25% had persistent, unchanged chronic 
pain 45% had a reduction in pain to mild or very mild, and 29% were pain-free. In the 
25% of patients that had persistence of severe chronic pain, the symptoms had a 
significant effect on all daily activities and quality of life, for example in measurement of 
general enjoyment of life, those with mild pain scored 2.32 (1.5-3.13) compared to 7.14 
(5.97 - 8.30) in those with persistent severe pain (P<0.05) .  
 vi
In the second study 63% of patients completed VAS scores at follow-up. Prior to surgery 
the majority of patients had no pain or only mild pain at rest (80.5%) or on movement 
(58.8%). At 1 year follow-up the mean (SD) VAS score reduced by 2.9 (1.2) at rest, and 
reduced by 9.2 (1.8) on movement. However the majority of the beneficial effect was 
seen in those with moderate to high preoperative pain scores. Those with a preoperative 
VAS score >10 had a reduction of 22.8 (3.7) at rest, compared to a slight increase in pain 
(+1.8) in those with no pain pre-operatively (P<0.05). Similar effects were seen on 
movement (improvement of 32.2 (4.8) in those with preoperative pain score >10, and 
little change in pain, -0.3 (1.6), in those with no, or only mild, preoperative pain 
(P<0.05).  
In the third study 162 patients received the PA mesh and 159 received the NA mesh. The 
PA mesh was not associated with less pain at 1 year postoperatively, compared to the NA 
mesh, with the proportion experiencing any pain being 39.5% in the PA group compared 
to 51.6% in the NA group (P=0.033). The proportion experiencing severe pain was 
similar, being 3% for the PA group and 4% for the NA group, and the recurrence rate 
was greater with the PA mesh compared to the NA mesh (4.9% versus 0.6%, P=0.037). 
 
Conclusion 
Of those with chronic severe pain at 3 months post inguinal hernia repair, the majority 
will have still have some pain at 30 months post operatively. The greatest benefit in 
terms of pain reduction in patients undergoing inguinal hernia repair is experienced by 
those with the more severe preoperative pain. From our data there is no clear overall 
benefit in using the PA mesh over the standard mesh, as whilst pain scores were slightly 
lower in the PA group, this was countered by a higher recurrence rate.  Further attention 
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to the multiple factors that contribute to pain post-inguinal hernia repair is required, 
including the development of superior mesh technology. 
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Chapter 1:  Review of Literature 
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  1.1. Introduction 
Approximately 96% of all groin hernias are inguinal hernias, with the remaining 4% being 
femoral. Hernias are bilateral in 20% of cases. The most common abdominal wall hernia is an 
inguinal hernia with a male to female preponderance of 9 to 1. Femoral hernias are more 
common in women 4 . 
 
Chronic pain is the most common and serious complication following inguinal hernia repair. 
In this thesis the role of chronic pain and its relationship to inguinal hernia repair is examined 
in three studies. In the first study the outcome of patients with chronic postoperative pain is 
assessed in a population based study.  In the second study pain attributed to the hernia is 
quantified preoperatively and compared with pain and or discomfort at a time interval of one 
year post surgery. The third study, a randomised controlled trial, examines the effect of mesh 
type on postoperative pain. A review of the pathophysiology of pain and the factors that 
influence pain is given. This is followed by a review of the current literature on surgery and 
chronic pain. The significance of these results, their influence, and their impact on current 
thinking regarding hernia repair is debated. Finally the relevance of our results to future 
studies is explored.  
 
 1.2. Definition of pain; what is chronic pain? 
The International Association for the Study of Pain (IASP) defines pain as an “unpleasant 
sensory and emotional experience associated with actual or potential tissue damage or 
described in terms of such damage”. This definition declares that pain, as well as having a 
physiological basis has a very real psychological or subjective component 5. 
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Transition between acute and chronic pain is defined by most authors in terms of time 5. The 
two most commonly used chronological markers to denote chronic pain have been three and 
six months since the initiation of pain, however these distinctions are arbitrary. The IASP 
provides one of the most referenced definitions of chronic pain. Chronic pain is that which 
persists beyond the normal time frame for healing, usually taken to be 3 months. The IASP 
considers a further characteristic related to the “appropriateness” of the disorder.  In acute 
pain there is an advantage to the individual, i.e. it allows rest and the inflammatory process of 
healing to occur.  In chronic pain there is no biological value, i.e. there is no advantage to the 
individual in experiencing persistent pain. The Clinical Standards Advisory Board for the 
National Health Service (NHS) defines chronic pain “as that which persists beyond the 
expected time frame for healing or that which occurs in disease processes in which healing 
may never occur” 6. The Practice Guidelines of the American Society of Anaesthesiologists 
for Chronic Pain Management considered chronic pain as a “persistent or episodic pain of a 
duration or intensity that adversely affects the function or well being of the patient, 
attributable to any non-malignant aetiology” 7.  Thus chronic pain may be as a result of the 
healing process gone awry. It may be persistent and unrelenting and conveys no benefit to the 
individual who experiences it.  Sternbach has emphasized the differences between acute and 
chronic pain and argues that while acute pain is a symptom of disease, chronic pain itself is 
the disease 8. 
 
It is not easy to classify pain. At best the classification is ambiguous and variable. As there is 
no consensus of agreement, there are a wide variety of classifications of pain. Pain can be 
classified based on anatomy, duration, aetiology, body system or severity. Portenoy 
categorised both acute and chronic pain as nociceptive, neuropathic or psychogenic 9. 
Nociceptive pain is due to chronic activation of nociceptive afferent neurones and can be 
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somatic or visceral. In nococeptive pain and pain due to tissue inflammation, the sensory 
experience reflects the normal, adaptive functioning of the pain system 10. Neuropathic pain 
is defined by the IASP as pain initiated or caused by a primary lesion or dysfunction in the 
nervous system 11. It is due on the other hand to central reorganisation of sensory processing 
after injury to an afferent pathway. It may be sustained by mechanisms that involve 
disturbances in the peripheral nerve or nerve root, i.e. peripheral neuropathic pain, or the 
reorganisation of nociceptive information processing by the central nervous system, 
deafferentation syndrome 12. Niv and Devor see neuropathic pain as a fundamental paradox, 
as injury to a sensory conduction pathway should decrease the signal transmitted not increase 
it 10. They argue that it is important to remember that what we describe as conduction 
pathways are in fact protoplasmic extensions of living structures, neurones, and that these 
cells will respond actively to injury with changes in biological properties. 
 
 1.3. Pathophysiology of chronic pain  
Possibly the most influential papers that contributed to the understanding of the 
neurophysiology of pain were published in the latter half of the twentieth century by Melzack 
and Wall 13, 14. Their Gate Control theory of pain emphasized the central nervous system as 
an active system that filters, selects and modulates the inputs of the peripheral nervous 
system. It also emphasized the dorsal horns as dynamic activity stations where inhibition, 
excitation and modulation can occur.  
 
The pathway for pain and temperature is known as the spinothalamic pathway. Nociceptors 
or pain receptors are non-encapsulated endings of peripheral nerves. Group α-delta fibres are 
thin and small and myelinated and carry the first sharp and well-localised impulse of pain. 
Neural impulses are transmitted rapidly at a rate of 40m/second. Group C fibres are larger, 
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coarser and unmyelinated and carry the second wave of diffuse pain slowly at < 2m/second. 
During inflammation, prolonged firing of C fibres causes increased production of glutamate 
that acts on n-methyl d-aspartate (NMDA) receptors leading to central sensitisation. NMDA 
antagonists can lead to decreased central sensitisation and thus the pain response can be 
modified 15. Any noxious stimulus that excites a local inflammatory response results in an 
influx of tissue cytokines and mediators. This causes the release of substance p and 
bradykinin and the beginnings of the pain pathway are ignited.  
 
The central processes of the primary afferents of spinal nerves constitute the dorsal roots, 
which break up into 12-15 rootlets that connect with the spinal cord. Larger axons go to the 
centre and medial part of the rootlets and to the centre part of the dorsal columns. The smaller 
myelinated fibres line up dorsolaterally and travel in the apex of the dorsal horns, dorsolateral 
pathway of Lissauer. Most primary afferent fibres terminate in the ipsilateral dorsal horn, but 
some course dorsal to the central canal and terminate in the contralateral horn. At this point 
interneurones within the substantia gelatinosa of the spinal cord can excite or inhibit the 
afferent impulse. Intraspinal opioids exert their primary effects on the substantia gelatinosa 
(lamina 11) of the spinal horn. Also exerting an influence on the dendrites of the substantsia 
gelatinosa are the axons of the raphe nuclei of the medulla, which travel in the reticulospinal 
tract. Thus descending pathways can influence the transmission in the ascending sensory 
tracts. Some axons of the substantial gelatinosa will also cross the midline in the ventral 
white commissural, these fibres continue upwards in the spinothalamic tract. They give off 
collateral branches that terminate in the medullar and pontine reticular formation and in the 
peraqueductal gray matter of the midbrain. The destination of the spinothalamic tract is the 
ventral posterior nucleus of the thalamus. Spinothalamic and medial lemniscus tracts 
terminate in the ventral posteriolateral division of the nucleus. The ventral posteriomedial 
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division receives the trigeminothalamic fibres. The axons of the ventral posterior nucleus of 
the thalamus cross the posterior limb of the internal capsule and the corona radiata to reach 
the somesthetic area in the parietal lobe 16. Thus the human body is projected as a 
homunculus in the parietal lobe, with areas such as the fingers having a disproportionally 
large representation 17. 
 
Melzack proposed a new extension on the gate control theory in the mid sixties (Figure 1.1.) 
18.  In this paper he states that the selection and the modulation of the sensory input through 
the neospinothalamic projection system provides the neurological basis of the sensory 
discriminative dimension of pain. Activation of reticular and limbic structures underlies the 
powerful motivational drive and unpleasant affect that trigger the organism into action. 
Neocortical or higher central nervous system processes, such as the evaluation of the input in 
terms of past experience, exert control over activity in both the discriminative and 
motivational systems. Pain was thus thought now to be a multi dimensional experience. He 
summarises that the sensory-discriminative, motivational-affective and cognitive-evaluative 
components of pain all coexist and are produced by a complex matrix of interacting brain 
structures. Thus noxious stimuli i.e. touching a naked flame, usually stimulate the pathway of 
pain. Then a beneficial response i.e. removal of the hand from the naked flame takes place. 
This is a sequence of reflex pathways and also of pathways under the influence of higher 
cortical control (one can keep the hand in the naked flame if so desired). When the noxious 
stimulus is removed i.e. local tissue or nerve damage, even if it is not easily identified, pain 
may persist. The terminology used to describe chronic pain illustrates the abnormalities of 
these neural networks. There appears to be a faulty rewiring that occurs to change a positive 
protective, beneficial response into a negative, distressing one. This hints at a normal 
pathway gone awry but it does not explain the underlying faulty mechanisms. Definitions of 
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pain descriptors also hint at an underlying faulty mechanism. For example allodynia is pain 
due to a stimulus that does not normally cause pain. Hyperalgaesia is an increased response to 
a stimulus that is normally painful and dysaesthesia is an unpleasant abnormal sensation 
whether spontaneous or evoked. The concept of plasticity in excitatory or inhibitory 
transmitter systems is becoming better understood and changes induced in peripheral and 
central nervous systems can lead to chronic pain.  Animal experiments on rats help to explain 
how acute pain becomes chronic, thus explaining plasticity 19, 20. As the rat sciatic nerve is 
temporarily tied off the rat exhibits acute pain behaviour. However when the sciatic nerve is 
released and the rat is sacrificed some time later there are signs of chronic pain via 
microscopic evidence of neural changes in the dorsal horn, spinal cord and brain 21, 22. 
Transmitter systems are different in the neonate and mature adult. That is, information is not 
transduced in the same manner from the moment of birth. There is plasticity or change and 
this is part of normal human development. 
 
 1.4. The economic burden of chronic pain 
In 1998, a study commissioned by the Department of Health attempted to assess the 
incidence of back pain, a typical and common example of a chronic pain condition, in Great 
Britain. Fifteen percent of suffers said that they were in pain throughout the year and nearly 
40% of suffers consulted their general practitioner (GP) for help. Ten percent visited a 
practitioner of complementary medicine. One third of those questioned, said that back pain 
had restricted their activities in the month prior to interview. Women and older people were 
more likely to report restriction of activity than men and younger people. Five percent of 
back pain suffers had taken time off work because of this pain. Thirteen percent of people 
who experienced back pain, and were unemployed, cited back pain as a reason as to why they 
were off work.  Chronic back pain, they state was a feature of age, with 28% of those over the 
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age of 65 years reporting pain for the whole year compared to less than 5% of people aged 
16-24 23. Back pain, as a major health problem in industrialised societies, was investigated by 
Maniadakis 24. They report the results of a “cost-of -illness” study of the socio-economic 
costs of back pain in the UK. It estimated that the direct health care cost of back pain in 1998 
to be £1632 million. Approximately 35% of this relates to services provided in the private 
sector and is thus most likely paid for by sufferers and their families. However they 
emphasise that the direct cost of back pain is insignificant compared to the cost of informal 
care and the production losses related to it, which total £10668 million 24. A similar study in 
the United States (US) state that rheumatoid arthritis and low back pain have a great 
economic impact on society and that the costs of these are escalating problems. As 
populations increase in size and age, payment for medical care and indirect costs from loss of 
earnings will increase 25. Murphy looked at annual low back pain claims over an eight-year 
period in the US and found that claims decreased by 34% over this period but that the trend 
was not monotonic 26. However at the end of the eight-year period, in 1995 an estimated $8.8 
billion was spent on low back pain claims and the rate of filing of low back pain claims was 
1.8 per 100 workers 26. In another study the average annual productivity losses per worker 
due to chronic backache were $1,230 for male workers, measured in 1996 dollars and $773 
per female worker. These figures translate into aggregate annual productivity losses from 
chronic backache of approximately $28 billion in the US 27.  In 2003 Blyth, from the 
University of Sydney, preformed a population based telephone survey to assess the effects of 
chronic pain on work performance 28. Employed subjects with chronic pain reported working 
with pain on an average of 84 days over a six-month period. Approximately 9% of subjects 
reported involvement in litigation. The factor they conclude most strongly related to pain-
related disability was being involved in pain related litigation. Most workers can work 
effectively despite the presence of some pain, suggesting that complete absence of pain is not 
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essential for good treatment outcomes in workers with chronic pain.  However being involved 
in litigation is associated with a substantial increase in the risk of pain related disability 28. 
Nurses in long term care facilities had a period prevalence of back injuries nearly 1.5 times 
higher than all employees of long term care facilities and six times higher than all other 
occupations combined industry wide. Back injuries accounted for more than half of the 
indemnity and medical costs for all injuries occurred in nursing homes industry wide 29.  
 
Chronic back pain is evidently associated with very significant financial burden both to the 
individual, to society, and to the economy of the nation. 
 
 1.5. The prevalence of chronic pain 
It is estimated that chronic pain can affect up to 40% of the adult population 30. This is much 
greater than the prevalence of cancer, with 2% of the population of the United Kingdom (UK) 
being alive, having received a diagnosis of cancer 31. It is about the same as the prevalence of, 
diagnosed and undiagnosed diabetes, approximately 2.5 million adults. Therefore, chronic 
pain represents a major clinical problem. Although differences in the definition of chronic 
pain have been used in epidemiological studies, differentiating chronic pain on the basis of 
severity appears to identify important subgroups 32. Chronic pain is commonplace within the 
community and its prevalence is widespread.  In general it does not seem to exhibit a gender, 
racial, class or age bias.  
 
Elliot et al undertook a study to quantify and describe the prevalence and distribution of 
chronic pain in the community 33. They found that 50% of their respondents self reported 
chronic pain and this is equivalent to 46.5% of the general population. Back pain and arthritis 
were the most common complaints and accounted for a 1/3 of all complaints.  They 
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concluded that chronic pain is a major problem in the community 33. In a four-year follow up 
study these same authors described the pattern and predictors of change in chronic pain over 
time. They concluded that the overall prevalence of chronic pain increased from 45.5% at 
baseline to 53.8% at follow up.  At the end of follow up 79% of those who had pain initially 
still had it four years later. The average annual incidence was 8.3% and the average annual 
recovery rate was 5.4 34. In their telephone study of 1037 households Bowsher et al found the 
prevalence of chronic pain sufferers to be at 7% 35. Geographical variations were noted, with 
the proportion of pain suffers in the south of England being half of that in the north. The 
mean age of chronic pain sufferers was forty-four. Roughly 51% were over the age of fifty-
four. Arthritis / rheumatism was the most common complaint, with the back and the lower 
limb being the most common locations affected 36. Crook et al in their random survey of 500 
households, found that the prevalence rate of persistent pain was almost twice that of 
temporary pain 37. More women than men reported temporary than persistent pain. Again the 
back and lower extremities followed by the head and face, were the most frequently 
identified sites of pain 37. The prevalence of chronic pain in non-westernised populations is 
unclear. In their study Ng et al, show that the prevalence of chronic pain in Hong Kong adults 
is approximately 10.8% 38. The female gender and age greater than 60 years were two risk 
factors identified for developing chronic pain. Work and daily life are significantly affected 
and there is considerable demand on the health care system. Despite the ethnic difference, the 
prevalence, pattern and demographic differences of chronic pain in Hong Kong were 
ultimately very similar to those seen in Western countries 38.  
 
On the 27th of February 2002, the Scottish Parliament debated the plight of chronic pain 
patients. The motion stated, “chronic pain was regarded as the most neglected health issue in 
Scotland”. The Clinical Standards Advisory Group cited a figure of 7% of the population as 
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suffering from chronic pain 39. This was thought to amount to between 350,000 and 500,000 
patients in Scotland. The Pain Research Institute in Liverpool was also quoted, citing “overall 
1 in 14 of all adults have chronic pain rising to 1 in 7 as people get older”. Petition PE 374 
called for the Scottish Parliament “to act urgently to investigate and redress the under funding 
of chronic pain management Services, to debate the matter in Parliament and to urge the 
Minister for Health and Community Care and Health Boards to move chronic pain up the 
health agenda”.  
 
Despite claiming to understand the position of chronic pain suffers, the Scottish Parliament 
stated that there were no immediate plans to conduct an audit of facilities and budgets for 
chronic pain relief in the NHS 39.  Recently in Ireland, where chronic pain is stated to effect 
13% of the population, it has been declared that a national strategy is needed to reduce cost, 
standardise teaching and to increase pain clinic resources to maximise patient care 40. 
 
It is very difficult to accurately quantify the number of people in the general population that 
have chronic pain of one type or the other 10.  Pain is stated to be the chief complaint in 40% 
of primary care visits and persistent chronic pain is reported in 20% 41. Open-ended questions 
tend to generate large numbers of responses from people, 50% answering in the affirmative 
33. Using the IASP definition, estimates of the prevalence of chronic pain are at 35% 42. 
Surveys that more closely define intensity and duration yield prevalence figures of around 
20% 43.  
 
Ospina reviewed recent epidemiological studies on chronic pain 42. It was argued that the 
variation in the prevalence of chronic pain can be attributed to the population sampled, the 
method used to collect the data and the definition of chronic pain used 42. From the analysis 
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of these studies the author felt that the frequency of chronic pain increased with age, was 
higher among women and that there was an association between social status and specific 
pain types. The weighted mean prevalence of chronic pain was 35.5% ranging from 11.5% to 
55.2%. They also noted that the method of data collection was an associated variable and 
contributed to the variations in prevalence.  
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Figure 1.1. Melzack’s gate theory of pain 44. 
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  1.6. Race and ethnic influences on chronic pain 
Progression to a chronic pattern of pain is more closely dependent on demographic, 
psychosocial and on occupational factors than on the medical characteristics of the pain itself 
45. Edwards et al show that there is an ethnic difference in terms of both clinical and 
experimental pain 46. They argue that the African-American population are more sensitive to 
noxious stimuli and therefore experience relatively greater clinical pain 46. In another study 
by the same authors, where responses to experimental thermal pain were evaluated in the 
African-American and White populations, the former group reported higher rates of 
unpleasantness than the latter group at similar temperatures 47. Group differences in terms of 
noxious stimuli were unchanged even when adjustment for psychological factors were made. 
They tentatively conclude that whites and African-Americans differ primarily in affective 
rather than sensory processing of noxious stimuli. Thus there may be fundamentally different 
physiological processes that contribute to explain the fact that racial differences exist in 
chronic pain 1. Racial differences in chronic pain are noted both in terms of healthcare 
provided and perception of chronic pain. Five commonly reported chronic pain conditions; 
back, head, face/jaw, chest and abdomen were examined in the context of race. Racial 
differences were not found for chronic pain of the back, head, chest and abdomen. However 
significant racial differences were found regarding facial pain and symptoms related to 
temporomandibular disorders above and beyond socio-economic status. Not only did 
Caucasians, compared to African-Americans report facial and jaw symptoms more 
frequently, but they were also reported to have an earlier onset  48. In a cross sectional study 
of chronic moderate to severe knee and/or hip pain in just fewer than 600 adult males, (44% 
African-American and 56% White), the severity of symptoms was compared with the extent 
of skeletal damage as ascertained by radiographs. The authors conclude that in this sample of 
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male veterans, African-Americans and Whites perceived the same degree of pain and 
functional disabilities at any given radiographic severity of osteoarthritis. Differences in the 
perception of symptoms, they argue cannot be therefore used to explain the observed ethnic 
disparity in utilisation of joint replacement. However, what exactly does explain this 
difference is unclear 49. Chronic pain, as perceived by six different ethnic groups, was 
examined in approximately 400 patients attending a multidisciplinary chronic pain centre. It 
seems that variation in pain intensity may be affected by differences in attitudes, beliefs and 
emotional and psychological states associated with the different ethnic groups. These authors 
concluded that while pain intensity variation was not significantly associated with diagnosis, 
present medication types or types of past treatment or surgeries for chronic pain, it is likely 
that attitudes and emotions influence reported perceptions of pain intensity 50. In a cross 
sectional study of seven cultural groups in Canada, considerable differences in the groups 
were found in the reporting of pain, emotional function and cognitive function 51. The 
variation in the scores across the cultural groups could not be explained in terms of socio-
economic status 51. In a review of the current literature Green et al suggest that African-
Americans with chronic pain report more pain severity and disability due to pain than non-
hispanic Whites 52. It is not clear, they say, whether these findings reflect under-treatment, 
over-reporting, differences in pain sensitivity or some combination of the above. They 
conclude that consistent with the Institute of Medicine’s report on health care disparities, 
racial and ethnic disparities in pain perception, assessment and treatment were found at all 
stages when assessed, and for all pain types assessed including chronic pain. The literature 
they state, suggests that the sources of pain disparities among racial and ethnic minorities are 
complex, involving patient (e.g. patient/health care provider communication, attitudes), 
health care provider (e.g. decision making), and health care system factors (e.g. access to pain 
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medication) 52. There is also data to suggest that chronic pain is relatively under-treated in 
racially and ethnically diverse populations 53.  
 
Therefore, whilst there is strong evidence that there are consistent and substantial differences 
in the experience of chronic pain between different racial and ethnic groups, there remains no 
clear explanation for these differences. An awareness of these racial and ethnic factors can be 
important considerations when interpreting and managing chronic pain.  
 
 1.7. Age and sex influences on chronic pain 
Animal experiments as well as observations in humans have shown that gonadal hormones 
influence somatosensory perception and pain sensitivity. These effects are exerted in part at 
least by the binding of oestrogen to oestrogen - receptors located in the superficial layers of 
the dorsal horn. Here, neurones containing oestrogen receptors contain m-ribonucleotide acid 
(RNA) for the endogenous opioid enkephalin, and administration of oestrogen has been 
shown to increase enkephalin transcription in the spinal cord 54. Craft et al found that opioid 
agonist analgesics act preferentially at mu receptors and are more potent in male rodents than 
in females, however the reverse effect is found in the human population. The possible 
mechanisms underlying these sex differences, however may deal with the pharmokinetics of 
the drugs or in their pharmodynamics 55. It has also been shown that reproductive age women 
have greater mu opioid receptor binding potential than men in numerous cortical and 
subcortical areas on PET scans, and this may account for their greater response to opioids 56. 
A recent study published this year in the Southern Medical Journal, evaluated whether there 
was a sex difference in the analgesic response to the prototypical mu receptor agonist, 
morphine sulphate, compared with the prototypical kappa agonist, butorphanol, in the 
emergency department 57. Patients attending the emergency room with moderate to severe 
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traumatic pain of injury were randomised to receive morphine or butorphanol. Both groups 
were similar in terms of demographics. At 60 minutes, women had significantly lower visual 
analogue pain scores (VAS) scores with butorphanol than with morphine. Therefore the 
authors suggest that kappa receptor agonists should be chosen preferentially for female 
patients with acute traumatic pain 57. Bush et al analysed symptom presentation, sensitivity to 
pain, personality and illness behaviour in two samples of patients suffering from chronic 
orofacial pain 58. The results showed few gender differences based on ratings of chronic or 
experimental pain, pain-related illness behaviour or personality. The higher ratio of women 
versus men with temporomandibular disorders seeking care is consistent, they say with 
greater health awareness or interest in symptoms by women than by men 58.  It is well 
established that women report more severe pain, more frequent pain and pain of longer 
duration than men. What is unclear is why they do so. Arguments varying from differing 
social rules for expression of pain to fundamental differing biological principles in the 
processing of pain have been put forward. In contrast to the previous paper, Dao et al, 
hypothesise that the higher prevalence of chronic orofacial pain in women is a result of sex 
differences in generic pain mechanisms and of as yet unidentified factors unique to the 
craniofacial system 59. There is also animal evidence to support this gender disparity 60. 
Fillingim in his study found that females are at greater risk of developing several chronic pain 
disorders and that women exhibit greater sensitivity to noxious stimuli in the laboratory 
compared with men 61. Psychosocial factors, such as sex role beliefs, pain coping strategies, 
mood, and pain related expectancies are all thought to contribute to this effect 61. Using 
imaging techniques gender differences of the brain were recently demonstrated in 
neurophysiological response and pain perception to heating of the skin. Thus gender 
differences in the biological processing of pain, in the perception of pain and in the action of 
certain analgesics exists 62. Chronic stable angina pain has detrimental effects on quality of 
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life, particularly in women. Although these authors found that men and women have 
similarities in terms of pain characteristics, but women report more physical limitations and a 
more intensity of pain than do men for similar extent of disease 63. Challenging the accepted 
evidence that women merely complain more when in pain, is a paper by Hunt et al 64. This 
looked at whether women or men were more likely to have consulted their general 
practitioner in the past year when experiencing five common chronic conditions.  They found 
that women were no more likely than men to consult their GP for common chronic 
conditions, nor were they more likely to consult at any given level of severity 64.  
 
It is well known that pain, both temporary and chronic increases with age. Population based 
studies estimate that 25-50% of community dwelling older adults report chronic pain 
problems 65, 66. In nursing home residents 45-80% of people experience chronic pain. This 
increase is thought to be due to the fact that a large number of the aged population here are 
female 67. However in a review of the literature on chronic pain and the elderly population, it 
was found that although there were considerably more female than male subjects in the 
studies reviewed, it was still difficult to determine whether older women’s experiences with 
chronic pain are unique and require special attention from health care providers or whether 
the causes, treatments, and consequences of chronic pain should be considered universal to 
the older population as a whole 12. A recent review of epidemiological studies show that the 
peak or plateau in the prevalence of pain is at age 65 30. There is a decline in reported pain in 
the old i.e. 75-84 years. The reasons underlying this are unclear, but factors ranging from the 
methodology of the studies reviewed to the impact of age – associated memory impairment 
and dementia have been postulated 68. When site of pain is looked at with respect to age it is 
seen that head, abdominal and chest pain frequency is reduced among older people, whereas 
musculo-skeletal joint pain increases slowly at least to 80 years of age 69.  There is some 
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limited evidence to support age related changes in the physiological functioning of the 
peripheral and central nervous system. A reduction in the density of myelinated and 
unmyelinated nerve fibres has been noted in the older adults 70. Nerve conduction studies 
indicate prolonged latencies in peripheral sensory nerves in apparently healthy older adults 71.  
 
 1.8. Psychology and its influence on chronic pain 
Depression or anxiety is diagnosed in 58% of patients with chronic pain 72. Coexisting 
psychological distress predicts the development of a more relentless chronic pain problem 73, 
74. Chronic pain has an important adverse effect on quality of life of the individual and on 
their spouses. There are several difficulties that researchers face when attempting to study the 
effects of chronic pain and its disability on the sexual well being of patients in this group. For 
example analgesics and other prescribed medication for chronic pain may interfere with 
sexual function, also sexual difficulties may predate the onset of chronic pain. In a UK study 
of 327 patients with chronic pain, the authors noted that 73% of those that responded had 
pain related difficulty with sexual activity. There were few differences noted between men 
and women and only weak relations emerged between specific problems and mood and 
disability 75. Fillingham et al indicate that the behaviour of the spouse has a strong impact on 
the pain and disability expressed by chronic pain patients 61. These authors note that “ female 
patients may need to display greater pain related disability to elicit supportive responses from 
their husbands, while the wives of male patients require less pain related disability to provide 
increased support” 61. This interpretation is aided by the earlier finding that the wives of male 
pain patients are more strongly affected by their husband’s pain and disability than the 
husbands of female patients 76. The effects of pain and depression on quality of sleep reported 
by suffers of chronic pain was investigated by a study conducted by the department of 
anaesthetics and psychiatry in Pennsylvania. They found that those patients who were more 
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physically active and had chronic pain of a shorter duration reported higher overall quality of 
sleep. Daytime sleepiness was associated with younger age and depressed mood. They 
conclude that their data suggests that physical functioning, duration of pain and age may be 
more important than pain intensity and depressed mood in contributing to overall quality of 
sleep 77. Depression is commonly reported among chronic pain patients. However it is largely 
unclear whether depression in this group of patients is as a function of pain, disability or 
gender. In this study of 63 patients, male and female depressed and non-depressed chronic 
pain patients largely did not differ in terms of demographic and medical history data but sex 
differences were found in patterns of the relationships of depression, activity and pain. For 
women depression was largely related to pain reported, whereas for men depression was 
more strongly related to impairment of activity 78. Chronic pain adversely impacts on mood 
as opposed to a negative mood being a predisposing factor in the development of chronic 
pain 79. Psychological and social factors have an important role to play in the adjustment 
towards chronic pain. In a multiple-regressional analysis, Jensen et al showed that 
psychosocial predictors made a statistically significant contribution to the concurrent 
prediction of average phantom limb pain. Pain interference and depression at initial 
assessment of the amputees was significant in predicting adjustment of patients to chronic 
pain at a 5 month follow-up 80. This paper argues the importance of considering bio 
psychosocial factors in chronic pain patients 80. Behavioural treatment of chronic pain has 
usually been along the lines of coping. Recently a study by McCracken et al aimed to 
compare a coping approach to pain with a different behavioural approach referred to as 
acceptance of chronic pain 81. Results showed that coping variables were relatively weakly 
related to acceptance of pain and relatively unreliably related to pain adjustment variables. 
On the other hand acceptance of chronic pain was associated with less pain, disability, pain 
related anxiety, depression and better work status 81.  
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 Individuals suffering from chronically painful conditions show elevated rates of suicidal 
ideation and suicide attempts. Fisher et al emphasise that when individuals with chronic pain 
report suicidal intent, it is imperative that measures preventing self-harm be implemented 
immediately and that patients’ depression be treated aggressively 82. 
 
Therefore, we have defined pain and chronic pain. We have reviewed the pathophysiology of 
pain in neuroanatomical terms. We have seen that chronic pain is present in all communities 
throughout the world. We know that there are subtle influences for example, age, sex, 
psychology and social factors that influence ones perception and determine the extent of 
chronic pain. Chronic pain, in general has an effect on the health of the nation as a whole and 
on the economy in particular.  The question then becomes how is all this relevant to the 
specific surgical procedures of hernia repair.  How can we modify the above influences on 
chronic pain and so avoid it?  The answer is not clear. This is because what affects a certain 
individual and results in chronic pain is largely unknown and certainly multi-factorial.  
 
It is often assumed that workers who are in the process of litigation exaggerate their pain for 
financial gain. However there is a growing body of evidence that people who receive workers 
compensation are no different from those who do not 83. 
 
 1.9. How to measure pain 
Pain is a subjective experience and as such it is difficult to precisely quantify it in an 
objective manner. Pain intensity like other sensations and perceptions displays considerable 
variability both across patients and within a patient across time 84.  Thus a logical approach 
and the use of validated tools are necessary to assess and quantify pain. Several different 
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tools have been constructed to achieve this aim. The importance of pain quantification lies in 
its role as an assessment tool and research tool. The advantages and disadvantages of the 
tools used most frequently to measure pain were reviewed comprehensively by Ong in 2004 
84. 
Pain therefore has an intensity that can be directly measured and it also has an effect on 
psychology and functional ability 85. Assessment and measurement of psychological distress 
and functional impairment is thus an indirect assessment and measurement of pain.  
 
The McGill Pain Questionnaire (MPQ) (Figure 1.2.) consists primarily of three major classes 
of word descriptors sensory, affective and evaluative that are used by patients to specify 
subjective pain experience 86. The questionnaire was designed to provide quantitative 
measures of clinical pain that can be treated statistically 86. It is sufficiently sensitive to detect 
differences among the various methods to relieve pain. The MPQ can be used in both clinical 
and laboratory settings and this means that similarities and differences in pain types can be 
clarified 87. It can also be used as a reliable index of the overall affective status of pain 
patients 88. It was one of the first pain assessment tools, however as it has been found to be 
detailed and time consuming a shortened version is available 44. An early study which 
illustrated that the MPQ is useful in the assessment of the reactive component of pain also 
suggested that further research into the autonomic indices as physiological correlates of the 
reactive aspect of pain 89 was indicated. The intensity rating of the individual words in the 
MPQ has been shown by Towery and Fernandez 90 to correlate very highly with those 
reported by Melzack and Torgerson 91. The words used in the MPQ are efficient and 
unambiguous in the clinical assessment of pain. 
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The psychological assessment of chronic pain is often accomplished using questionnaires 
such as the West-Haven-Yale Multidimensional Pain Inventory (MPI or BPI or BPQ) (Figure 
1.3.), which is constructed to capture the multidimensionality of chronic pain. The MPI 
theoretically originates from behavioural and cognitive behavioural theories of pain 92. The 
MPI meets standards of reliability and convergent validity and is thought to be an 
improvement over current psychometric devices 93. The advantage of the MPI is that it has 
been shown to be accurate and reproducible across various cultures and therefore is suitable 
for cross cultural and international research 94 . The MPI was developed in order to fill a 
widely recognized void in the assessment of clinical pain 95. It is a clear and short 
questionnaire with a strong psychological component. It examines the impact of pain on 
patients’ lives, the responses of others to the patients’ communications of pain and how 
chronic pain impacts on activities of daily living. It has been compared with the SF36 in 
noncancerous patients and found to give similar results 96. As well as being found to be 
reliable and valid 97, it has also been found to be sensitive to changes in chronic pain 
conditions 96. 
 
Simpler measures to assess and quantify pain include visual analogue pain scales (VAS) 
(Figure 1.4.), numeric rating scales and verbal rating scales. The VAS measures pain on a 
100mm scale. Pain is marked along this line from 0 to 100. When data from over 11 
randomised controlled studies was analysed it was found that 30 or less equated to mild pain, 
31 to 54 equated to moderate pain and that greater than 55 was equivalent to severe pain. 
When pain was scored as 55 or more, that is severe pain, it was noted that this usually 
corresponded to functional interference 98. At the time of constructing these studies for this 
thesis there was no precise definition as to the significance of mild, moderate and severe pain. 
Subsequently Chow et al 99 examined how patients with bone metastases categorized their 
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pain using two commonly employed scales. Patients rated their pain on a visual analogue 
pain scale of 0 -10 (0 = no pain, 10 = worse pain possible) and a categorized scale of none, 
mild, moderate and severe. Based on patient evaluated symptoms, 60% of patients describing 
mild pain gave it a numerical rating of 3 or 4, 63% of those who described pain as moderate 
scored it as a 5, 6 or 7, and 80% who categorized it as severe gave it a numerical value of 8, 9 
or 10. They concluded that pain was mild if given a numerical value of 1-4, moderate if 
scored between 5-7 and severe if > or = 8 99. Again what point on the VAS indicates or 
reflects moderate pain was investigated by Collins et al 100. In their study, 85% of patients 
reporting moderate pain scored over 30mm on a corresponding VAS with a mean of 49mm. 
Those patients who described severe pain scored a mean of 75mm with more than 85% 
scoring over 54mm. They found no difference between men and women. They concluded that 
if a patient records a baseline VAS in excess of 30mm then the equivalent in terms of the four 
point verbal categorical scale is at least moderate pain. 
 
The Faces Pain Scale (Figure 1.5.) is a communication tool. It is a schematic drawing of 
happy and sad faces in a linear fashion that depicts the intensity of children’s pain. It has been 
validated in studies to show that it has the properties of a scale 101. Overall the Faces Pain 
Scale incorporates conventions used by children, has achieved strong agreement in the rank 
ordering of pain, has indications that the intervals are close to equal and is treated by children 
as a scale. It is a reliable index of self reported pain with time.   
 
The Numeric rating scale rates pain from 0, no pain to 10, severe pain. Its use in clinical 
research is however controversial 102. Verbal rating scales allow the individual to rate pain 
verbally from none to mild to moderate to severe. 
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Deloach 103 compared changes in VAS scores compared to verbal assessment of changes in 
pain in the acute postoperative period. He concluded that the single VAS score in the 
immediate postoperative period should be considered to be imprecise to a degree of 20mm. In 
general the VAS is an appropriate tool for the assessment of postoperative acute and chronic 
pain as it corresponds well to an 11 point verbal scale but they stress that any individual 
measurement may actually vary by 20mm in either direction. Gallagher 104 using paired data 
comparing clinically significant changes in pain versus changes in VAS measurements,  
showed that a difference of 13mm on a VAS represents an average minimal change in acute 
pain that is clinically significant. Kelly 105 asked the question does clinically significant 
changes in VAS vary with sex, age and cause of pain and found that it does not.  Kelly  106 in 
2001 determined that the minimal clinically significant difference in VAS pain scores that 
can be detected does not vary according to severity of pain. This means that if you improve a 
little or a lot, or deteriorate a little or a lot, the VAS will pick this up. McCarthy 107 
constructed four visual analogue scales, referred to as the Surgical Pain Scales (SPS) to 
assess sensory and affective components of postoperative pain. The SPS can be used 
therefore, to compare pain measures between groups at a single point in time or to track 
change for individual patients over time or after operations 107.  
 
Pain is known to alter the electrogalvanic properties of the skin. In a small study, 
postoperative patients were assessed for pain severity using the numeric rating scale and non-
fluctuating skin conductance by blinded observers. Skin conductance has a predictive 
sensitivity of 89% and specificity of 74% and it has been therefore suggested that it may  
prove a useful tool for postoperative pain assessment 108. 
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Figure 1.2. McGill pain questionnaire 86.  
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 Figure 1.3. Multidimensional (West-Haven-Yale) pain inventory or brief pain inventory 97. 
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Figure 1.4.  Visual analogue pain scale. 
 
 
 
 
 
 
Figure 1.5. Faces pain scale. 
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The Short Form 36 was developed in 1988 and the standard form was brought out in 1990.  It 
is a multipurpose short form survey of functional health and well being. It is a generic 
measurement as opposed to one that targets specific age, disease or treatment group. It is a 
useful in surveys of general and specific populations in differentiating health benefits 
produced by a wide variety of treatments. There have been several peer reviewed articles 
about the SF36 in terms of its history, development, reliability and validity 109.  Over the past 
decade it has been modified and improved. It is the most widely evaluated quality of life 
patient assessment form that is available. Diseases most frequently studied using the SF36 
include depression, cancer, COPD, back pain and arthritis. It has been translated into many 
different languages. It has been constructed to satisfy minimum psychometric requirements 
for group comparisons. It came about as an amalgamation of inventory used in the seventies 
and the eighties 110. It is available in both standard four week and the acute one week recall 
versions. The latter is more sensitive to recent changes in health status. The physical and 
mental health variances detected have been shown to be reliable in the US population, and 
among populations in Sweden 111 and in the UK 112.  The reliability of the 8 scales and two 
summary measures has been estimated using both internal consistency and test retest 
methods. It is reliable and can be replicated over different patient groups and different 
socioeconomic backgrounds. Studies of validity generally support the intended meaning of 
high and low SF 36 forms as documented by Ware et al  113.  It has been shown to be valid in 
content and in comparison to more in depth questionnaires or measurements 114. 
  
Because it is short, the SF36 can be reproduced in a questionnaire with ample room for more 
precise general and specific measures and studies have been done which illustrate the 
advantage of supplementing the SF36. Other assessment questionnaires are 5-10 times longer 
and convey greater respondent burden, ie the advantage of the SF36 is that it is short, brief 
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and comprehensive. Experience from over 400 randomised controlled trials has shown that 
SF36 is a useful tool for evaluating benefits of alternative treatment methods 114. 
 
  
 1.10. Chronic pain in relation to surgery 
Chronic pain can be an unexpected adverse outcome following surgical procedures. 
Alternatively surgical intervention can be used to treat the chronic pain of disease, benign or 
malignant. In a recent study the results of surgery for chronic pancreatitis of varying 
aetiology were evaluated. One of the postoperative outcome measures was degree of pain 
control. The authors suggest that surgical resection should be preformed when required by the 
anatomical conditions as it is associated with good long term pain control, 71.4% achieved 
complete pain control at an average follow-up of 6 years 115. There are a wide number of 
surgical treatments available for the chronic pain of pancreatitis with no single surgical 
technique being superior to the other 116. In a study, which looked at the outcome of women 
following hysterectomy for non-malignant conditions, 18% of the population underwent 
surgery for chronic pelvic pain. The authors report that hysterectomy resulted in marked 
improvement in a range of symptoms including pelvic pain, urinary symptoms, fatigue, 
psychological symptoms and sexual function 117. In a consensus statement for the 
management of chronic pelvic pain associated with endometriosis, these authors conclude 
that there is some evidence that adjuvant presacral neurectomy adds benefit for midline pain 
but that hysterectomy alone has undocumented value in the surgical management of women 
with chronic pelvic pain related to endometriosis 118. Chronic pain is also well recognised as 
occurring as part of the malignant process. It has been shown that cancer patients report 
higher values of physical interference than non cancerous chronic pain patients with the same 
level of pain intensity 119.  The operation of anterolateral open cordotomy for intractable pain 
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of malignancy was evaluated over a ten-year period. The effect of this procedure on the 
patient group was evaluated over three years or until death. The results show that 95% of 
survivors had an effective relief from pain at discharge and that this fell to 73% at 6 months 
and to 55% at one year follow up 120.  The first study to quantitatively compare chronic post 
surgical pain using similar methodologies in heterogeneous populations was reported in 2004 
121. This study found that the prevalence and characteristics of chronic pain was remarkably 
similar across different operative groups. The surgical procedures evaluated were 
mastectomy, inguinal hernia repair and cardiac surgery with or without saphenous vein 
grafting. This was a retrospective study that compared chronic postoperative pain in patients 
operated upon over a ten-year period. The prevalence of chronic pain after inguinal hernia 
repair in this study was 30% and was found to be sensory-discriminative in quality 121. 
 
Chronic pain as an unexpected consequence of common surgical procedures was reviewed 
recently 122. This article detailed the incidence of chronic pain following cholecystectomy, 
thoracotomy, mastectomy, and limb amputation. The incidence of phantom limb pain is 
thought to vary from 30-81%.  Stump pain is also common with an overall incidence of 60% 
123.  Following breast surgery, pain can be experienced in the chest wall, breast or scar (11-
57%), as phantom breast pain (13-24%) or as arm /shoulder pain (12-51%). The post 
thoracotomy pain syndrome is thought to have an incidence of approximately 50% 124. 
Chronic abdominal pain following gallbladder surgery is common and ranges from 3-56%. 
The frequency and the intensity of chronic pain, as well as the related factors, were assessed 
in a cohort of breast cancer patients in a recent retrospective study. Patients who had 
completed their treatment at least 6 months previously and deemed free from cancer were 
studied. Although almost half of the early stage breast cancer patients experienced post 
treatment chronic pain they rated the intensity of their pain as mild to moderate. Younger age 
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and receiving radiotherapy were factors that contributed to developing chronic pain. Chronic 
pain did not however interfere, seriously with life function125. Recently chronic postoperative 
pain has been analyzed following cardiac surgery, specifically coronary artery bypass 
grafting (CABG).  The cumulative prevalence of post cardiac surgery chronic pain was 
39.3%. The prevalence of chronic pain decreased with age, 55% in those patients less than 60 
years and 34% in those less than 70 years. Patients with preoperative angina and those with a 
body mass index (BMI) > 25 were more likely to report pain as were those who had lower 
quality of life scores 126. Chronic pain following Caesarean section has also been investigated 
127. The average follow up period was 10.2 months. These authors state that while most pain 
resolves, in 5.9% of women chronic post Caesarean pain is a significant problem. These 
patients were more likely to have undergone general rather than spinal anaesthesia 127. 
Perkins recently described a model, which details the origins of chronic pain (Table 1.1) 122.  
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Preoperative factors Intraoperative factors Postoperative factors 
Pain (moderate to severe) 
lasting >/= 1 month 
Surgical approach and risk 
of nerve damage 
Acute pain (moderate to 
severe) 
Repeat surgery  Radiation therapy to area 
Psychological vulnerability  Neurotoxic chemotherapy 
Workers’ compensation  Depression 
  Psychological vulnerability 
  Neuroticism 
  Anxiety 
 
 
Table 1.1. Predictive factors for chronic pain as per Perkins 122. 
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They argue that it is by understanding the aetiology of chronic pain in a particular individual; 
we are then better placed to manage and/or treat it effectively. So far treatment modalities are 
educative guesswork. There are no true reproducible animal models available. Animal studies 
at best infer cause. Perkins reviewed post thoracotomy chronic pain syndrome, post 
mastectomy chronic pain and post herniotomy chronic pain in terms of three stages, 
preoperative, intraoperative and postoperative 122. Physiological and psychological factors 
come into play pre and post operatively. Post-thoracotomy pain syndrome (PTPS) is at its 
most severe 12 months following surgery 128 .  It is in the order of 40% at 12 months. 
Anterior or muscle sparing thoracotomy is least painful but there is no difference in chronic 
pain reported when the video assisted thorascopic approach is compared to open 
posteriolateral thoracotomy. Preoperative state, anxiety or depression traits were not related 
to long-term pain. However acute postoperative pain was a predictor of long-term pain. Loss 
of intercostal nerve function was also related to long-term pain. This supports the theory that 
local anaesthetic infiltration of the thoracotomy wound, intra and immediate postoperative 
thoracic epidural are associated with a decrease in long-term postoperative pain 129, 130. 
Chronic pain does decrease with time i.e. from one to twelve months 131. Following breast 
surgery postoperative pain includes chest wall, breast or scar pain, phantom breast pain and 
ipsilateral arm and /or shoulder pain. The incidence of chronic pain at 12 months in one or 
more of the above sites is in the order of 50%. Preoperative breast pain is a predictor of 
postoperative chronic pain, i.e., phantom breast pain but not other types. Preoperative anxiety 
and depression are more common in those with chronic pain but this is not statistically 
significant. Breast conserving surgery is more likely to be associated with chronic pain as is 
mastectomy with implantation. High acute postoperative pain scores are associated with long-
term pain. Chronic breast pain decreases with time i.e., after 12 months whereas chronic arm 
pain may not.  
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1.11. Chronic pain and inguinal hernia repair 
Inguinal hernia surgery has advanced considerably over the past two decades. Despite this, 
the average general surgeon is still uncertain as how best to manage patients with an inguinal 
hernia both pre and post operatively. Over the years inguinal hernia repair has evolved from 
sutured to mesh repair. Mesh repair brings with it the advantage of low recurrence rate (< 
5%) and is the most common method of repair 1.  There is less postoperative pain following 
mesh rather than sutured repair of an inguinal hernia 132. One of the perceived disadvantages 
of this type of repair appears to be an increase in the reporting of post-operative pain and 
discomfort 133, 134-136. Chronic postoperative inguinal hernia pain can be severe and 
debilitating. It has a negative effect on the individual in terms of lifestyle and work. This may 
also have a negative effect on the economy when one considers the number of repairs 
performed. Inguinal hernia repair has an annual procedural rate of 2,800 per million people in 
the United States alone.  Approximately 70,000 hernias are performed in the UK in a given 
year 137. Given the frequency of post herniorrhaphy pain, it is not entirely clear whether the 
surgeon should be repairing inguinal hernias in all patients 138 . Are patients best served by 
repairing all hernias even in those patients with little or no discomfort from their hernia 139? If 
we decide on repair, when and how best should it be done?  
 
More recently in 1987, Ralph Ger first described laparoscopic hernia repair and since then 
there have been numerous modifications and advances on his original technique 140. Does 
laparoscopic inguinal hernia repair per se reduce chronic postoperative pain? If mesh repair is 
associated with chronic pain does reducing the size, shape or composition of the mesh alter 
this association in any way? How, when and with what type of mesh should we be repairing 
an inguinal hernia, in order to minimise or avoid post-operative chronic pain?   
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In 1999 Callesen et al published a prospective consecutive case series study that examined 
the incidence of chronic postoperative pain at one-year post elective day case local 
anaesthetic hernia repair. Pain was scored at rest, on coughing and at mobilisation as none, 
mild, moderate and severe at one year and compared with data collected at one and four 
weeks post repair. Just fewer than 20% of patients reported some degree of pain at one year. 
The incidence of moderate to severe pain was higher after repair of a recurrent hernia. Those 
patients who complained of persistent pain at one year were more likely to have high pain 
scores at one week and four weeks post surgery. Thus they concluded that the intensity of 
early postoperative pain is a good predictor of long term chronic pain 141. Another study in 
1999 compared long-term outcome following local anaesthetic open mesh repair with the size 
of the hernia as found at operation. In total 220 hernias were repaired and the average follow-
up was 15 months.  Most patients (approximately 90%) were able to do sports and perform 
usual activities of daily living including driving within 4 weeks of surgery. Chronic 
unpleasant postoperative sequelae were classed as mild or moderate pain, local 
hypoaesthesia, and weather dependent changes in sensitivity and hyperaesthesia. This study 
found that those patients most likely to complain of moderate pain at one-year follow-up 
were those that had a small intra-operative hernia. The authors did not find a relation between 
pain of any sort and age and sex of the patient. They conclude that patients with small intra-
operative hernias are not necessarily well served by surgery 142. The Cooperative hernia study 
assessed postoperative pain in a prospective trial as part of a larger study looking at the 
recurrence rate and other morbidity of the Bassini, McVay and Shouldice repair. Just over 
three hundred patients were randomised to one of the repairs. At two years 50% of patients 
had some degree of pain and 10% had moderate to severe pain. They concluded that the 
predictors of long term post operative pain include, absence of visible bulge preoperatively, 
numbness in the immediate postoperative period and the need for the patient to spend 4 
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weeks or more off work postoperatively 143. One year after inguinal hernia repair, pain is 
common at 28.7% and is associated with functional impairment in more than half of those 
with pain 144 . In 2003, Poobalan et al reviewed all studies to date on chronic pain post 
inguinal hernia repair 145. In their own follow up study they identified a cumulative 
prevalence of chronic pain of 30% at 3 years post surgery. One third of this 30% reported 
moderate to unbearable pain. The definition of chronic pain used by these authors was that 
used by the IASP. As stated by these authors standardization of definition, length of follow 
up and quantification of chronic pain is lacking. Direct comparisons between studies to tease 
out causative factors are therefore difficult if not impossible. This is illustrated in the study by 
Amid et al 146. The descriptor of chronic pain that they used was neuralgia and among other 
reasons is an explanation for their low chronic pain result 146.  Pain during sexual activity and 
subsequent sexual dysfunction represent a clinically significant problem in about 3% of 
younger male patients with previous inguinal herniorrhaphy 147. Intraoperative nerve damage 
and disposition to other chronic pain conditions are the most likely pathogenic factors. 
Chronic pain post inguinal hernia repair ranges from 0 – 63% and is usually broadly 
classified into three categories mild, moderate and severe. Severity may be determined by 
extent of interference with social, daily and work related activities, number of painkillers 
used and attendance at chronic pain clinics.  Perkins looked at post herniorrhaphy pain in the 
context of their chronic pain model and estimated that it may be as high as 50% at one year 
122. They believe that the presence and extent of preoperative pain may influence the degree 
of postoperative pain. Some authors would argue that it is not imperative to repair all hernias 
as soon as they are detected. In the context of postoperative chronic pain there is a defined 
point where the surgeon must intervene, quantifying this point however is not clear. Repair of 
recurrent hernia and type of mesh used may be related to long-term chronic postoperative 
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pain. The results of chronic pain studies in response to detailed questionnaires are 
summarised in Table 1.2. 
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 Author Year Surgery Sample 
Size 
Time to 
Follow-up 
Response 
Rate 
 
Chronic 
Pain 
Incidence
Cunningham143 1996 Sutured 818 12 months 
24 months 
36% 63% 
54% 
Callesen141 1999 Mesh 466 12 months 93% 19% 
Schmitz142 1999 Mesh 186 15 months 75% 36% 
MRC group3 1999 Laparoscopic 
and open 
928 12 months 91% 29% 
37% 
Poobalan136 2001 Mesh and 
sutured 
351 36 months 65% 30% 
Bay-Neilson144 2001 Mesh and 
sutured 
3265 12 months 
48 months 
80% 29% 
18% 
 
 
Table 1.2. Results from chronic pain studies that used detailed questionnaires.  
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 1.12. Preoperative factors that may contribute to post herniorrhaphy chronic pain 
Chronic groin pain, as well as being a consequence of inguinal hernia repair, may also be as a 
result of a previously undiagnosed hernia. A small bulge in the posterior wall of the inguinal 
canal may not be large enough to be clinically detected but may account for chronic groin 
pain.  Surgical mesh repair of this small direct hernia has been reported to alleviate in 87% 
and improve in the remainder of cases, previously unexplained chronic groin pain 148. This 
study had fit sportsmen as its population base. In another similar study surgical exploration 
and repair of a previously undiagnosed inguinal hernia should be undertaken in sportspeople 
unable to compete due to chronic groin pain. That is, when all other explanations of chronic 
groin pain are exhausted, a clinically silent groin hernia may be the explanation for chronic 
groin pain 149. The majority of patients that present with an uncomplicated hernia report a 
protruding mass and /or pain or discomfort in the groin 150. As many as 66% report pain at the 
time of initial presentation and this increases to 90% in those patients that have their hernia 
for 10 years or more 151. What degree of preoperative pain needed to make repair worthwhile 
is not clear. For the patient to believe that the surgical experience has been worthwhile, the 
reduction in preoperative symptoms has to be greater than the risk of severe postoperative 
chronic pain and more than chronic pain per se. Arguments supporting repair are based on 
alleviating symptoms and avoiding the risk of an acute hernia accident, the latter being often 
estimated at between 4 and 6% 152. However because large population based studies detailing 
the natural course of an untreated hernia are scarce, this commonly held assumption that the 
life time risk of strangulation is between 4 and 6% is more likely one of speculation than fact. 
In the study by Hair et al the incidence of bowel resection was 0.3% , indicating that the risk 
of strangulation is approximately 1 in 300 151. 
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1.13. Anatomy and physiology of the inguinal canal 
A thorough knowledge of the anatomy and function of the preperitoneal space and groin 
region is required by any surgeon with an interest in the surgical management of groin 
hernias. The position and variability of nerve structures should be understood, irrespective of 
whether the surgeon is approaching the hernia from the anterior (open mesh repair as 
described by Lichtenstein 153) or posterior route (laparoscopic transabdominal 154 or 
preperitoneal procedure 155 ).  
 
The nerves encountered using the anterior approach are the ilioinguinal and iliohypogastric 
nerves as well as the genital branch of the genitofemoral nerve. The ilioinguinal is usually 
smaller than the iliohypogastric and may be absent. These two nerves arise from the first 
lumbar nerve and are both mixed sensory nerves. The ilioinguinal nerve passes through the 
inguinal canal, under cover of the external oblique and becomes superficial at the external 
ring. It innervates the skin of the scrotum and the medial upper thigh. Damage to the 
ilioinguinal nerve in the inguinal canal causes sensory loss as the motor fibres have already 
been given off to the conjoint tendon. The iliohypogastric nerve emerges through the external 
oblique aponeursosis to innervate the supra pubic skin. It may be damaged when the superior 
aspect of the mesh is stapled or sutured underneath the upper leaf of the external oblique. 
 
The nerves of most importance to the laparoscopic surgeon are the genitofemoral nerve, the 
lateral cutaneous nerve of the thigh, and the femoral nerve. The genitofemoral nerve comes 
from the first and second lumbar nerves and completes the innervations of the groin region. It 
passes obliquely through the substance of the psoas major muscle and emerges from this 
crossing deep to the peritoneum and the ureter. It splits behind the deep inguinal ring into the 
genital and femoral branches. The genital branch lies on the floor of the inguinal canal behind 
 41
the spermatic cord and supplies the cremasteric muscle via its motor branches and the scrotal 
skin via its sensory branches. The femoral branch contributes to the sensation of the anterior 
thigh. The lateral cutaneous nerve of the thigh crosses the iliacus muscle after emerging from 
the lateral border of the psoas muscle. It passes beneath the iliopubic tract just medial to the 
anterior superior iliac spine and innervates the skin on the anterior and lateral surface of the 
thigh. The femoral nerve is the largest of the three nerves and lies deep to the iliopsoas fascia. 
It can be seen emerging between the psoas and iliacus muscles, passing beneath the iliopubic 
tract and innervating the muscles of the anterior compartment of the thigh and the skin of the 
anterior aspect of the lower thigh and leg 156. 
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Figure 1.6. The pre-peritoneal pelvic anatomy with the iliopsoas fascia partially excised to 
expose the femoral nerve on the right side. 
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Figure 1.7. Position of the nerves from the anterior approach in the right inguinal canal. 
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1.14. Intraoperative factors that may contribute to post herniorrhaphy chronic pain 
Chronic pain can be neuropathic or nociceptive in origin. Neuropathic pain is believed to be 
as result of nerve damage and is usually described as electric, sharp and shooting pain. 
Nociceptive pain on the other hand is as a result of tissue damage and is described as aching, 
heavy and dragging 86. There are three nerves of anatomical and physiological importance in 
the groin area that may contribute to chronic post inguinal herniorraphy pain of neuropathic 
origin. These are the ilioinguinal, iliohypogastric nerves and the genital branch of the 
genitofemoral nerve.  
 
Ducic et al believe that severe and chronic postoperative testicular pain after inguinal surgery 
can be treated by a designed approach that identifies the genital branch of the genitofemoral 
nerve in the proximal inguinal canal, resects it proximal to the previous operative field and 
subsequently places it behind the peritoneum 157. From cadaveric anatomical studies that 
highlighted the variability in the course of this nerve as it exited the external ring, they 
showed that proximal ligation of this nerve provides relief of chronic scrotal pain. Despite 
this being a small study, all four patients had relief of subjective symptoms and evidence of 
objective improvement with reduction in level and frequency of pain postoperatively. Al-
Dabbagh et al reviewed the anatomical variations in the course of the ilioinguinal and 
iliohypogastric nerves in 110 hernia repairs 158. They found that the course of both nerves was 
consistent with that found in anatomical textbooks in just fewer than 50% of cases. This 
difference in the variation of the nerve along its pathway may leave it susceptible to injury at 
operation. However these differences in the course of the nerves can be readily appreciated 
and should be easily identified by the surgeon. 
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Since the early 1980’s peripheral nerve entrapment syndrome following common surgical 
procedures to the lower abdominal wall have been recognised. Ilioinguinal or iliohypogastric 
nerve entrapment is typically diagnosed as a burning pain near the incision that radiates to the 
area supplied by the nerve with associated impaired sensory perception. Resolution occurs, 
albeit temporarily, when the two nerves are infiltrated with local anaesthetic as they leave the 
internal oblique. Surgical repair of the scar and resection of the nerve was advocated as the 
method of treatment for this condition 159. It is important to note that this early study involved 
very small numbers and that at least 25% of their patients had persistent chronic pain 
following the proposed treatment. In 1996 Bower et al reported that severe chronic 
postoperative inguinal hernia neuralgia was rare 160. They suggested that in the small number 
of patients in whom non operative methods of treatment were refractory, the involved nerve 
should be mapped out prior to its surgical high ligation and division 160. Understanding the 
typical nerve anatomy and variation, is fundamental in treating this rare but debilitating 
postoperative complication.  A larger series of just under 500 patients, this time confining the 
surgical procedure to the sutured Shouldice repair of an inguinal hernia, states that inguinal 
entrapment syndrome can be reduced to below 2% if the genital branch of the genitofemoral 
nerve is deliberately dissected free or cut cleanly 161. The early postoperative complication 
rate or the recurrence rate is not affected 161. Again, identifying the nerve and ligating it is 
advocated as a solution for severe chronic neuralgic pain which these authors state is 
uncommon but debilitating following hernia repair 160.  Dittrick et al reviewed 90 patients 
who underwent Lichtenstein inguinal hernia repair over a seven year period 162. The two 
surgeons who performed the operations differed in the fact that one preformed ilioinguinal 
neurectomy on a routine basis. Neuralgia and paraesthesia were assessed through telephone 
and personal patient interviews at 1 month, 6 months, 1 year and 3 years post surgery. There 
was no data recording preoperative symptoms or no data on potential confounding conditions 
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e.g., stroke, diabetes etc. They concluded that the incidence of postoperative neuralgia was 
significantly lower in the neurectomy group versus the nerve preservation group at 1 month 
and 1 year but there was no significant difference in postoperative neuralgia at 3 years, 
though they did admit that numbers followed up at 3 years were small. At the same time the 
incidence of postoperative paraesthesia was not significantly higher in the neurectomy group 
versus the nerve preservation group at 1 month, 1 or 3 years. Those that reported 
postoperative paraesthesia in the neurectomy group at one month and six months had lower 
mean scores on the visual analogue scale than those in the nerve preservation group. These 
authors argue that routine division of the ilioinguinal nerve is a reasonable option during 
inguinal hernia repair 162. The drawback of this study was that it was retrospective and that 
small numbers of patients were used. Recently a double blind randomised controlled study 
was published in the Archives of Surgery from Italy 163.  In four centres, 813 patients were 
randomised to inguinal hernia repair with either preservation or elective transection of the 
ilioinguinal nerve. The primary outcome was chronic pain at one year. At one year pain was 
absent in 76% of those with nerve preservation and in 73% of those with nerve transection. 
The majority of patients that reported pain had mild to moderate pain. However at 1 and 6 
months postoperatively loss of pain and touch sensation were significantly greater in the 
group with the iliioinguinal nerve transected. Touch sensation remained decreased in the 
group with nerve transection even at one year follow up 163. The problem with nerve studies 
is that in the main they evaluate the lack of function of one nerve only whereas there are three 
nerves involved in the sensory innervations of the groin.  
 
In a second Italian study the identification and preservation of all three nerves during open 
mesh repair was associated with a reduction in chronic incapacitating groin pain and in the 
majority of these patients with chronic pain at six months the pain was resolved with 
 47
conservative or medical management at 1 year 164. Madura et al state that the incidence of 
post herniorrhaphy neuropathies is not well known but is estimated to be in the region of 0 to 
30% 165. They argue that the most successful treatment is surgical resection of the nerve with 
good pain relief. Complete pain relief was seen in 72% of patients in their study and 10% 
reported a marked decrease in their symptoms. The only difference between patients who had 
complete relief and those who had partial relief of their symptoms was previous repair of a 
recurrent hernia. This seems to be the only available indirect evidence of chronic pain post 
repair of a recurrent inguinal hernia. To date there are no available studies that look at the 
incidence of post herniorrhaphy pain in patients who have had recurrent hernias repaired. One 
would assume that there is a higher incidence of chronic pain in these patients as tissue and 
nerve damage is twice as likely second time round. As an indirect result of our first study we 
found that patients who had a recurrent hernia repaired were no more likely to report pain at 
three months post surgery than those who had a primary hernia repaired. 
 
Therefore one can argue that chronic postoperative pain is partly explained by nerve damage 
at initial surgery. When any of the nerves are not recognised and as a result traumatised, 
chronic postoperative pain can ensue. However it would appear that the situation is not clear. 
While cleanly dividing the nerves does not exacerbate postoperative pain it does play a role 
in disturbed sensory changes after repair. On the other hand clean nerve division can also be a 
solution for severe chronic neuropathic pain. It has been postulated that when these nerves 
are caught or trapped in permanent stitches or tacks or bound up in the mesh during the 
various methods of repair it is then that postoperative chronic neuropathic pain may result. 
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1.15. Characteristics of mesh types 
Successful treatment of abdominal wall hernias and the prevention of recurrence is largely 
due to the insertion of a mesh. Meshes are synthetic alloplastic materials and are thought to 
work by mechanical sealing or by induction of a strong scar plate. Irrespective of which way 
the groin hernia is approached, meshes are necessary and indeed paramount to ensuring the 
low recurrence rates of less than 4% 166. The incorporation of a large amount of biomaterial 
can lead to seroma development, wound contracture and reduction in abdominal wall 
mobility. Meshes show migration and erosion of bladder and bowel with the formation of 
fistulas and bowel obstruction. It has been postulated that the very structure of the mesh and 
its inflammatory characteristic may contribute to post herniorrhaphy discomfort and pain. 
The host reaction is influenced by the mesh type used, particularly the amount of mesh used 
and the pore size. The optimum amount of material and pore size needed to adequately treat 
the hernia and avoid recurrence is unclear. Textile analysis of the various mesh types 
available show variations in weight, structure, stiffness and strength. There is an asymmetry 
to meshes in that different strain properties are seen in the horizontal and vertical direction. 
The basic mesh type is composed of polyprolene monofilament and this has a high bending 
stiffness. Increasing the size of the pores 167 and replacing part of the polyprolene 
multifilament with polyglactin results in a lighter partially absorbable mesh. Vipro 11 mesh 
has equal parts of absorbable polyglactin and non-absorbable polyprolene thread and an 
additional violet polyglactin and polyprolene thread placed rhombically over the mesh. After 
absorption of the polyglactin component the polyprolene mesh remains. It is this which has 
been optimally designed to cope with the physiological stresses of the abdominal wall. The 
main purpose of implantable meshes is their tensile strength. This can be defined by the 
modified Law of La Place, which states that F = P x d / 4, where  F = force (in Newtons, N) 
per cm2,  P = intra abdominal pressure (in kiloPascals, kPA) and  d = diameter (cm) 168. 
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Assuming an intra abdominal pressure of 20 kPa, the calculated tensile strength is a 
maximum of 16 N/cm2  169. This corresponds to the measured strength of tearing sutures out 
of tissues and exceeds the forces applied for suture repair of hernias. The tensile strength of 
Vipro 11 after 90 days, that is, when the polyglactin component is absorbed is 19.6 N/cm2 
(standard deviation 6.9) 170. This suggests that the minimal tensile strength required may 
actually be less than 16 N/cm2.  The differing textile properties of a non-absorbable standard 
mesh (Atrium) and a partially absorbable mesh (Vipro11) are compared in Table 1.3. 
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  ATRIUM (NA) mesh VYPRO 11 (PA) 
mesh 
material polyprolene polyprolene 
polyglactin 
Type of filament monofilament multifilament 
Weight (g/m2) 90.2 54.6 
Pore size (um) 800 5000 
Maximum tensile strength(N/5cm) 
vertical 
horizontal 
 
245 
616 
 
387 
63 
Subsequent tearing force(N) 
vertical 
horizontal 
 
3.7 
4.1 
 
1.1 
1.2 
Forces tearing out the seam(N) 
vertical 
horizontal 
 
58.8 
56.2 
 
29.6 
29.0 
 
 
    Table 1.3. Textile properties of mesh materials. 
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The asymmetrical tensile strength property of meshes has been studied by Junge et al 170. 
These authors found that when the mesh is fixed at opposite ends there is a difference in 
elongation and strength in both directions between partially absorbable and non-absorbable 
meshes.  
 
Another important property difference between these two mesh types is the suture pull out 
force. That is the force the sutures exert on the mesh filament in a particular direction. The 
sutures require to be less than or equal to the innate strength of the mesh so they are not 
pulled out. Much less effort or strength is needed to distort the partially absorbable mesh than 
is required for the non-absorbable polyprolene one. From in vitro experiments, Junge et al 
demonstrated that to prevent the sutures from being pulled out it is imperative that they are 
sutured 1 cm from the edge of the mesh 170 .  
 
1.16. Laparoscopic hernia repair and chronic pain 
In the year 2001/2 95.9% of patients in the UK had their primary hernia repaired at open 
surgery, only 4.1% of patients with a hernia had a laparoscopic repair 137.  The first report of 
a hernia repaired laparoscopically was in 1982 by Ralph Ger 171. Since then many surgeons 
have contributed to modifications and improvements on the original technical description but 
only 5% of surgeons have adopted this technique into routine surgical practice 172. 
Laparoscopic hernia repair can be done either transabdominally or extraperitoneally, using 
either general or regional anaesthesia. The advantage of laparoscopic inguinal hernia surgery 
lies in the fact that the whole of the inguinal floor on both sides is exposed and as a result 
direct, indirect, contralateral and femoral hernias can be detected and repaired. It also has the 
advantages of laparoscopic surgery in general, in terms of recovery period and incision 
length. The last decade has witnessed enthusiastic investigation comparing laparoscopic 
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versus open inguinal surgery repair. Approximately four meta-analyses, two systematic 
reviews, nearly 70 randomised controlled trials (RCT) and numerous retrospective reviews 
have been published 172. The problem with many of the RCTs is poor quality. Many are not 
well designed and have been found to be underpowered 172. Patients recruited to both open 
and laparoscopic repair groups were not necessarily homogeneous. End points that are easily 
measured i.e.; hernia recurrence, length of operation, are usually reported accurately but more 
subjective endpoints i.e.; postoperative pain, type of pain and return to normal activities are 
not usually reported in a standard quantified manner except in a few circumstances 172. The 
European Union (EU) hernia trialists’ collaboration has organised the most extensive meta-
analysis to date and continues to accrue data to constantly refine its conclusions. In the 
Group’s 2000 review, recurrence rates for open and laparoscopic repairs were not 
significantly different. In 2002, the Groups’ opinion was that return to normal activity is 
faster after laparoscopic repair and that persistent pain is less 173. In a five year follow up 
study laparoscopic hernia repair is shown to be associated with less long-term numbness and 
probably less pain in the groin than open mesh repair 174. Kumar et al found that chronic pain 
or discomfort was reported by 30% of patients after groin hernia repair and was significantly 
more common after open mesh repair than after laparoscopic total extra peritoneal repair 
(TEP) repair 175. It restricted physical or sporting activities in 18% of patients and specifically 
more so after open mesh repair 175 . 
 
Postoperative neuralgia following laparoscopic repair was examined by Fitzgibbons et al, and 
they found that leg pain decreased significantly from 7% to 1.8% after the surgeon preformed 
30 cases 176. Chronic pain and neuralgia occurs with an incidence of 0.5% and 4.6% 
respectively depending on the laparoscopic method used and as the surgeon becomes more 
familiar with the normal anatomy and its variants this incidence decreases 172 . 
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 1.17. Postoperative factors that may influence post herniorrhaphy chronic pain 
Adequate analgesia in the postoperative period is a priority in enabling the post-surgical 
patient to cope with the tissue damage of surgery. Irrespective of whether the hernia is 
repaired under local, regional or general anaesthesia, the patient will not be deemed fit for 
discharge until the pain of surgery is controlled with appropriate analgesia. Inguinal hernias 
have been repaired under general, regional or local anaesthesia. 
 
It is well established, for example that open inguinal hernia repair can be conducted under 
local anaesthesia, regardless of comorbidity and with minimal morbidity 177. Paravertebral 
blocks (PVB) have recently been used as the sole anaesthetic technique and randomised 
against general anaesthetic (GA) fast tracking for inguinal hernia repair. Patients who had 
their hernia repaired using PVB were discharged sooner, ambulated earlier, had less 
postoperative adverse events including acute postoperative pain than those in the GA group 
178. Patients’ general fitness for anaesthesia and preference are important in determining what 
type of anaesthesia is ultimately chosen. Despite this and despite the fact that local or 
regional anaesthesia is safe, cost effective and shown to decrease postoperative pain in 
inguinal hernia 179 repair,  the majority of anaesthetists choose GA to facilitate this surgical 
procedure 180. In a randomised controlled trial comparing post operative pain following 
inguinal hernia repair under general or local anaesthesia (LA), the only difference noted 
between the two groups was a reduction in pain scores noted at six hours in the LA group. All 
patients underwent psychometric testing and pain score assessments at 6, 24 hrs, 3 months 
and one-year post repair. Regional anaesthesia is also an option but appears to be used 
exclusively only by hernia specialists 181.  It is thought that acute post inguinal hernia surgery 
pain, that is pain in the first few days and weeks following surgery can influence the 
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development of long term chronic pain. Therefore adequate and effective immediate 
postoperative pain control not only determines timing of discharge but may also contribute to 
a reduction in chronic pain. It has been suggested that treatment designed to prevent pain in 
advance of surgical trauma may be more effective than simply instituting analgesic therapy in 
response to the pain after surgery 182. The benefit of local anaesthetic field block before 
hernia surgery has been investigated by Tverskoy et al 183. They reported that constant pain 
and incident pain were less severe for 48 hours after surgery in patients who received a 
preoperative field block with bupivicaine compared with patients who received no local 
anaesthetic at all. Inguinal field block is superior to local anaesthetic skin infiltration in terms 
of less pain postoperative pain until day 7, increased patient satisfaction, faster mobilisation 
and lower analgesic consumption 184 Analgesia in advance of the pain stimulus prevents 
central sensitisation and neuronal hyperexcitability i.e., “wind-up”. Central sensitisation is 
thought to be dependent on painful stimuli acting on NMDA receptors located within the 
central neuraxis 185. Pre-emptive treatment with local anaesthetics, anti-inflammatories or 
NMDA inhibitors have all been proposed as methods of inhibiting transmission of noxious 
stimuli thereby preventing stimulation of NMDA receptors and central sensitisation 182, 185. 
Thus the idea is to dampen the pain pathway before it even starts. Pre-emptive treatment 
using a single agent is often not sufficient enough to demonstrate a significant clinical 
difference 186. Pre-emptive therapies may have more success when used in combination than 
when used alone 187.  Pavlin and co-workers combined preoperative use of a non-steroidal 
anti-inflammatory drug (NSAID), an NMDA inhibitor and an LA field block was compared 
with a standard LA field block in terms of pain reduction post inguinal hernia repair. Despite 
small numbers, this study did show that trimodal therapy with a NSAID, NMDA inhibitor 
and LA field block prior to inguinal hernia repair led to a reduction in pain scores and 
analgesic consumption in the first 24 hours after surgery. The authors did admit that it was 
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unclear whether it was a true pre-emptive effect or an additive effect of various analgesics 
that was demonstrated 188.   
 
1.18 Current treatment options for those with post herniorrhaphy pain. 
  
Although health care providers are becoming better educated about the science of pain 
management 204, it is clear from some authors that there is an educational void when it comes 
to caring for those  patients with chronic pain of any aetiology 205.   
In the majority of cases patients who have post herniorrhaphy pain are not troubled by it. 
When assessed by questionnaire, only a half of those with severe pain seek medical 
assistance. Fewer still are referred back to their operating surgeon, while only a small group 
see a pain specialist. In a small number of cases chronic severe pain will persist post repair. 
For these people quality and function of life is affected. We have found that with time the 
pain disappears in 30%, becomes mild in 45% and continues to be severe in the remainder.  
 
The management of patients with severe pain is largely based on empirical management of 
other chronic pain conditions. The treatments available fall into the following groups, 
physical (acupuncture), drugs (analgesia, tricyclics), nerve blocks and psychological support. 
Dependence on long term analgesics is common. Patients should be referred to pain clinics 
for further management.  
 
In some cases the removal of the mesh may be necessary, but this is usually only undertaken 
when all other methods are exhausted. The role of surgery in patients with chronic pain is 
contraversial, some report excellent results with neurectomy with or without mesh removal. 
Mesh removal is usually confined to those with severe adverse psychological response to 
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their mesh. In a recent retrospective study the incidence of chronic pain and recurrence was 
examined at 44 months in patients who had to have the mesh removed for chronic groin 
sepsis and infection. These authors found 14 out 2139 patients over an eight year period that 
required removal of the mesh for infection. At the time of follow up, none had chronic pain 
and two had evidence of asymptomatic hernia recurrence 206. 
 
The essence of inflammatory or nociceptive pain is that it is ultimately protective. The human 
body has adaptive mechanisms for fighting infection and repairing damaged tissue. This 
occurs at a local level and also at a more complex tertiary level where there is an inter play 
between the physiological reactions of fight and flight. The body can eliminate the cause of 
inflammatory or nociceptive pain by using built in local mechanisms, for example diffuse 
noxious inhibitory controls, distraction or the endogenous opiate systems. The body however 
has little control or ability to recover from neural injury. It is poorly adapted to restore 
optimal functioning after injury or disease, which cause major damage to the nervous system 
Neuropathic pain seems to persist indefinitely. It is difficult to treat or modify, as our 
understanding of it is relatively poor. We can describe it in analogous terms but this merely 
simplifies it. 
 
Two families of systemically administrated drugs, anticonvulsants and tricyclic 
antidepressants, have statistical success in the treatment of neuropathic chronic pain. They do 
not however provide complete relief. Oral formulations bring about a 50% reduction in pain 
intensity in only about half of clinical trial subjects. Intra-venous administration of local 
anaesthetic agents works better but not in reality this is not practical 207. These medications 
have side effects including significant sedation, somnolence and nausea. The use of opiates 
which pharmacologically engage intrinsic pain inhibitory circuits are no longer relevant in the 
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treatment of chronic neuropathic pain208. A possible explanation for this is that nerve injury 
induces down regulation of mu-opiate receptors in primary sensory neurones in the central 
spinal terminals and their postsynaptic spinal targets 209.  As a result opiates become less 
effective. Neurolysis is invasive and as a result carries significant risks. It does work but 
transiently. It is not unknown for the pain to return more severely than it was initially. The 
process of neuromodulation, that is, of implantable devices, overcomes the transient success 
of neurolysis. However these devices are expensive and the procedure is still an invasive one. 
Topical agents offer moderate relief from superficial skin tenderness i.e., pain of nociception. 
They unfortunately do not offer relief for the ongoing evoked deep pain. Ilioinguinal 
neuropathy can be detected using nerve conduction studies and has been reported in a case 
study 210 to be successfully treated albeit temporarily by local anaesthetic blocks and 
permanently by complete transection of the ilioinguinal nerve.. 
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Chapter 2:  AIMS  
 
From a previous retrospective study documenting groin hernia repair in Scotland over a one 
year period 1, patients were questioned about the presence and severity of pain at three 
months post hernia repair. This is the period beyond which normal tissue healing is expected 
to have occurred. The aim of the first study was to assess the outcome of patients who 
complained of severe or very severe pain at three months following groin hernia repair. The 
main outcome measures included the number of patients with persistent pain and the effect of 
pain on daily activities and quality of life. Secondary outcome measures included the 
presence of other chronic pain conditions. 
No previous studies have attempted to quantify pain from a primary inguinal hernia. The aim 
of the second study was to quantify patients’ pain from a primary inguinal hernia at rest and 
on moving and to assess the effect of hernia repair on this pain. The patients were those who 
attended one hospital as part of a seperate multicenter trial 2. 
The aim of the third randomized controlled study was to compare outcome in terms of pain 
using a partially absorbable or light weight mesh and a non-absorbable or heavy weight 
mesh. The primary endpoint of the study was the incidence of chronic pain of any severity at 
the site of hernia repair at 12 months. 
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Chapter 3:  Outcome of patients with severe chronic pain following repair 
of a groin hernia. 
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 3.1. Introduction 
Severe chronic pain is the most serious long-term complication that can occur after repair of a 
groin hernia. In the past it has been thought to occur rarely, but more recently prospective and 
population based studies indicate that up to 6% of patients may have moderate to severe pain 
one year following this surgery 141.  Overall approximately 1/3 of patients will report some 
form of pain at one year after the operation 144. 
 
Given that groin hernia repair is a common procedure with an annual rate of repair of 100-
150 per 100,000 of the population, in a country the size of the UK, over 5000 new patients 
may suffer moderate to severe chronic pain each year. This has obvious cost implications for 
the Health service and the economy as a whole. Many of these patients delay returning to 
work and normal activities. In some cases they may not even be able to resume previous 
employment 189. 
 
In this first study we report the outcome of patients who had severe or very severe pain three 
months after groin hernia repair. This is the period beyond which normal healing is assumed 
to have occurred and fulfils the definition of chronic pain as stated by the International 
Association for the Study of Pain.  
 
 
3.2. Patients and Methods 
Ethical approval was obtained from the Institutional Ethics Committee of the Western 
Infirmary, Glasgow. Between April 1998 and March 1999 data was gathered on patients who 
underwent groin hernia repair in Scotland 1.  At a minimum of three months after surgery all 
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patients were sent a modified SF-36 questionnaire (appendix 1). This questionnaire evaluated 
their outcome and satisfaction with the surgical procedure. All patients were asked if they had 
pain in their groin at the site of the hernia repair at any point in the past week. In addition 
men were asked if they had pain in their testes on the same side. Those that had pain were 
asked to grade it as very mild, mild, severe or very severe. Patients were also asked about 
numbness around the groin and in the thigh on the side of the hernia operation. 
 
Patients who reported severe or very severe pain were sent a further questionnaire (appendix 
2) in April 2001. In addition to the modified SF-36 they were asked about the character of 
their pain and were asked to complete a Wisconsin Brief Pain questionnaire 97  
(Table 3.1. Flow diagram).  The latter is designed to assess the effect of pain on general 
activity, mood walking ability, normal work, personal relations, sleep and enjoyment of life. 
Patients score 0 if pain does not interfere with the previous activities to a maximum of 10 if it 
completely interferes. The words used to characterise the patient’s pain were based on 
previous studies 190 that set out to validate verbal responses for neuropathic (related to nerve 
damage) and nociceptive  (related to tissue damage) pain.  
Also patients were asked if they suffered from other chronic pain conditions such as chronic 
backache, headache, irritable bowel syndrome or any other chronic condition associated with 
pain.  
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Table 3.1. Flow diagram of patients for Study 1. 
 
                                   
5506 patients sent 
SF-36 three months post hernia surgery 
4062 (74%) response rate 
 
 
 
↓ 
125 (3%) patients complained of severe 
or very severe pain @ three months 
 
 
 
↓ 
86 (72%) patients completed SF-36 @ 
two and half years later 
 
 
 
 ↓ ↓ ↓ 
25 (29%) 
No pain 
reported 
 
39 (45 %) 
Mild or 
very mild 
pain 
22 (26%) 
Severe or 
very severe 
pain 
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3.3. Statistical analysis 
The statistical analysis was carried out using Statistical Package for Social Sciences (SPSS) 
for Windows, version 9.01 (SPSS Chicago, Illinois, USA). A chi squared or Fisher’s exact 
test was used to examine any association between different variables and whether the pain 
was very mild, mild, severe or very severe. A T-Test was used to examine the effect of 
chronic pain on daily activities and quality of life. Data are presented where appropriate with 
95% confidence intervals.  
 
 
3.4. Results 
Information was gathered on 5,506 patients who had a groin hernia repair in Scotland in 
1998. Of these 4,062 (74%) returned the modified SF-36 questionnaire. 1,733 (42.6%) still 
had very mild or mild pain while 125 (3%) had severe or very severe pain at the site of their 
hernia repair. Patients with severe or very severe pain were significantly (p <0.001) younger, 
that is 54 versus 60 years of age and more likely to be female (odds ratio 1.73, 95% CI 1.07-
2.81) when compared with the total population that had a hernia. There was no association 
between hernia type, primary or recurrent, operation type, mesh or non mesh, grade of 
operator and whether the operation was performed as a day case or not and incidence of 
severe or very severe pain following operation.  
 
In April 2001, a median of 30 months (range 24 to 36 months) after groin hernia repair 86 
(72%), of the 120 patients (5 had either died or could not be contacted at the original address) 
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with severe or very severe pain replied to the second questionnaire (Table 3.4.1.). Twenty- 
five (29%) recorded no pain at the site of their hernia while 39 (45%) described the pain as 
very mild or mild. Twenty- two (26%) still had severe or very severe pain. Of the 61 patients 
with pain, 39 (64%) had groin pain, 1 (2%) had testicular pain while 21 (34%) had both groin 
and testicular pain. Seventeen patients (28%) described the pain as continuous while thirty-
six (59%) felt that the pain was brought on by activity. Twenty-six (43%) had returned to 
their general practitioner with pain while eighteen (29%) had returned to their surgeon. Five 
(8%) had further surgery while 9 (15%) had attended a pain clinic. Unfortunately the 
outcome of these latter 14 patients is not clear.  Patients with severe or very severe pain were 
significantly more likely to seek further treatment when compared with those experiencing 
mild or very mild pain post repair, 19 of 22 versus 10 of 39 (p=0.0001).  
 
3.4.1. Effects on daily activities and quality of life 
The presence of chronic pain interfered significantly with all of the activities measured 
irrespective of the degree of severity of the pain (p=0.0001). Not surprisingly this effect was 
more marked in the severe/very severe group (Table 3.4.2).  
 
3.4.2. Character of pain and numbness 
The most common descriptor of pain used in this study was aching (45%) followed by 
throbbing (28.3%) and stabbing (23.3%). Patients with very mild or mild pain were more 
likely to describe their pain using a single term that indicated that the character of their pain 
was either neuropathic or nociceptive. In contrast patients with severe or very severe pain 
were more likely to use multiple descriptors to describe their pain. This would tend to suggest 
that the cause of severe chronic pain is both neuropathic and nociceptive in origin (Table 
3.4.3). Numbness was present in significantly more patients in the severe or very severe 
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group 18 of 22 versus 18 of 38 (p=0.001) (Table 3.4.4). In addition the numbness was more 
extensive in these patients and was likely to involve both groin and thigh.  
 
3.4.3. Other chronic pain conditions  
Patients in the severe / very severe group were significantly more likely to suffer from other 
chronic pain conditions when compared with the very mild/mild pain group (20 of 22, versus 
23 of 37, p=0.016). The most common illness was chronic back pain in both groups while 
significant numbers also had suffered from headache and irritable bowel (Table 3.4.5). Other 
conditions causing chronic pain in these patients included pain from scars elsewhere in the 
body and peptic ulcer disease.  
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 Patient demographics  
Age* [median (IQR)] 54 years  (40-66) 
Male 74   (86%) 
Female 12   (14%) 
  
Hernia type  
Primary 73   (84.8%) 
Recurrent 13   (15.0%) 
Bilateral 7     (8.1%) 
Inguinal 83   (96.5%) 
Femoral 3     (3.5%) 
  
Operation type  
Open mesh 77 (89.5%) 
Open non mesh 8   (9.3%) 
Laparoscopic 1   (1.2%) 
  
Principle surgeon  
SHO 16   (18.6%) 
Registrar 27   (34.0%) 
Staff Grade 8     (9.3%) 
Associate Specialist 2     (2.3%) 
Consultant 33   (36.4%) 
 
Table 3.4.1. Details of patients, hernia and operation type and grade of surgeon performing 
the operation who completed the second questionnaire. 
*Values are median (interquartile range); other values in parentheses are percentages. 
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 Mild (38*) Severe (22) 
General activity 2.29 (1.61 - 2.97) 6.55 (5.54 -7.55) 
Mood 1.78 (1.14 - 2.43) 6.45 (4.94 - 7.97) 
Walking 2.34 (1.55 - 3.13) 6.05 (4.80 - 7.29) 
Work 2.59 (1.73 - 3.45) 6.45 (5.26 - 7.65) 
Relationships 1.42 (0.69-2.15) 5.05 (3.40 - 6.70) 
Sleep 1.32 (0.76 - 1.92) 6.41 (5.33 - 7.49) 
General enjoyment of life 2.32 (1.5 - 3.13) 7.14 (5.97 - 8.30) 
 
 
Table 3.4.2 Effect on daily activities and quality of life values, given as mean (95% 
confidence interval). * One patient did not complete this section. 
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  Mild (38*) Severe (22) P value 
Neuropathic 
Aching 15  (39.5%) 12   (54.5%) NS 
Burning 3    (7.8%) 4     (18.2%) NS 
Cutting 0    (0%) 2     (9.1%) NS 
Electric shock 0    (0%) 0     (0%) NS 
Itching 1    (2.6%) 1     (4.5%) NS 
Prickling 3    (7.8%) 1     (4.5%) NS 
Shooting 7    (18.4%) 4     (18.2%) NS 
Stabbing 7    (18.4%) 7     (31.8%) NS 
Tingling 3    (7.8%) 2     (9.2%) NS 
    
    
Nociceptive    
Drilling 0    (0%) 0      (0%) NS 
Gnawing 5    (13.2%) 5      (22.7%) NS 
Pounding 1    (2.6%) 1      (4.5%) NS 
Pulling 3    (7.8%) 11    (50.0%) 0.001 
Sickening 2    (5.3%) 4      (18.2%) NS 
Tender 5    (13.2%) 8      (36.4%) 0.027 
Throbbing 5    (13.2%) 12    (54.4%) 0.001 
    
    
3 or more words 6    (15.8%) 13    (59.1%) 0.001 
 
 
Table 3.4.3 Descriptors of pain. * One patient did not complete this section. 
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  Mild (38*) Severe (22) All patients (60) 
Groin 12 (31.5%) 5 (22.7%) 17 (28.3%) 
Thigh 1   (2.6%) 0 (0%) 1    (1.6%) 
Both 5   (13.1%) 13 (59%) 18 (30 %) 
 
 
Table 3.4.4 Numbness (p< 0.001). * One patient did not complete this section. 
 
 
 
 
 
 Mild (37*) Severe (22) All patients (59) 
Backache 17 (45.7%) 17 (77.3%) 34 (57.6%) 
Headache 7   (18.9%) 6    (27.3%) 13 (22.0%) 
Irritable Bowel 4   (10.8%) 7    (31.8%) 11 (18.6%) 
Other 5   (13.5%) 3    (13.6%) 5    (8.5%) 
 
 
Table 3.4.5 Other chronic illnesses (p=0.016). * Two patients did not complete this section. 
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Chapter 4:  Pain from a primary inguinal hernia and the effect of repair on 
pain. 
 71
 4.1. Introduction 
Recent evidence indicates that up to one third of patients undergoing hernia repair have a 
painless hernia that has little or no effect on work or leisure activities 151.  However following 
operation it is now apparent that 3-6% of patients will have severe pain and as many as 30% 
will have mild pain at one year after hernia repair 141.  
The aim of this study was to quantify patients’ pain from an inguinal hernia at rest and on 
moving and to assess the effect of hernia repair on pain. 
 
 
4.2. Patients and Methods 
All patients undergoing elective repair for a primary inguinal hernia who were admitted to the 
care of one surgical unit, (Western General Infirmary, Glasgow) between January 1998 and 
October 2000 were entered into the study. Ethical approval was obtained from the 
Institutional Ethics Committee of the Western Infirmary, Glasgow.  Patients were asked to 
complete a linear analogue pain score of the degree of pain caused by the hernia at rest and 
on movement. Pain scores were recorded on a 100-mm line, where 0 represented no pain and 
100 the most severe pain, by a single observer 24hr before operation (appendix 3). The 
surgical procedure performed for a groin hernia was a standard Lichtenstein open mesh 
repair. At one-year post repair pain scores were again recorded and all patients were 
clinically examined for evidence of a recurrence at this time. Arbitrarily a score of less than 
10 was graded as mild pain, a score of 10-50 as moderate pain and a score of more than 50 as 
severe pain. 
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4.3. Statistical analysis 
Differences between groups were analysed using the Student’s t-test. Where there was 
sufficient doubt about the validity of parametric assumptions (assessed graphically), a Wilcox 
on or Mann-Whitney U test was preformed. 
 
4.4. Results 
A total of 323 patients with a primary inguinal hernia underwent an open tension free mesh 
repair during the study period. Characteristics of the patient group are shown in Table 4.4.1. 
The majority of patients had no pain from their hernia, or only mild pain, at rest (80.5%) or 
on moving (58.8%). Only 1.5% experienced severe pain at rest and 10.2% had severe pain on 
movement prior to repair (Table 4.4.2). 
 
Patients older than 50 were significantly more likely to have pain associated with the hernia 
on movement, than their younger counterparts (p<0.01). Surprisingly there was no 
association between hernia type, direct or indirect, or patient occupation and the presence of 
pain at the hernia site. Although women were more likely to have pain at rest and on moving, 
this effect was not significant and is likely to reflect the small number of women (17) in the 
study (Table 4.4.3). 
 
At 1 year after operation 204 patients (63.2 %) returned for clinical review and completed 
pain scores from the hernia repair site at rest and on movement (Table 4.4.4). This is the 
complete response rate despite several attempts at contacting patients both via GP, by phone 
and by letter. The low repeat response rate is thought to be explained by the fact that the 
questionnaires were labour and time intensive as they were part of a much larger and 
different study. The time taken to complete the questionnaire was approximately an hour. It is 
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also well known that low response rates are frequently seen when patients in clinical trials are 
seen by a variety of doctors 191.  Only 24.5% of patients had no pain at rest and only 21.6% of 
patients had no pain on moving. Overall the group showed a significant reduction in pain 
scores at rest (p=0.019) and on moving (p<0.001) compared with preoperative levels. This 
was due mainly to the large effect observed in patients with high preoperative values (Table 
4.4.5). In contrast, patients who had no pain at rest before operation had significant pain 
scores at rest at 1 year (p<0.001). No patient had recurrence of the hernia or other chronic 
complication at the one-year follow up visit.  
 
 
 74
  
 
 Number of patients  
( n = 323) 
Age               > 50 years 201 (62.2%) 
                     <  50 years 122 (37.8%) 
  
Sex                 Male 306 (94.7%) 
                       Female 17 (5.3%) 
  
Site                 Right 170 (52.6%) 
                        Left 127 (39.3%) 
                        Bilateral 26 (8.0%) 
  
Type               Direct 176 (54.5%) 
                        Indirect 147 (45.5%) 
  
Occupation   Moderate manual 57 (17.6%) 
                      Heavy manual 53 (16.4%) 
                      Sedentary 72 (22.3%) 
                      Retired 141(43.7%) 
 
 
Table 4.4.1. Patient characteristics. Values in parentheses are percentages. 
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 At rest On moving 
No pain    (0) 86 (26.6%) 53 (16.4%) 
Mild         (< 10) 174 (53.9%) 137 (42.4%) 
Moderate (10-50) 58 (18.0%) 100 (31.0%) 
Severe      (> 50) 5 (1.5%) 33 (10.2%) 
 
 
Table 4.4.2. Severity of pain in 323 patients. Data given is, number of patients (% of total). 
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  At rest 
mean (S.D) 
On moving 
mean (S.D) 
Age                 > 50 years 7.5  (11.9) 18.5  (23.8) 
                       <  50 years 6.7  (13.0) 14.4  (19.6) 
   
Sex                 Male 6.8  (12.2) 16.2  (21.9) 
                       Female 12.0 (14.6) 28.7  (29.2) 
   
Site                 Right 6.7  (12.4) 18.2   (23.4) 
                       Left 7.9  (13.1) 15.1   (20.3) 
                       Bilateral 5.1  (7.5) 16.5   (26.1) 
   
Type               Direct 7.4  (12.8) 16.4   (22.5) 
                       Indirect 6.7  (11.8) 17.3   (22.5) 
   
Occupation   Moderate manual 9.0  (14.7) 17.4   (20.4) 
                      Heavy manual 5.9  (13.7) 16.0   (19.8) 
                      Sedentary 5.8  (9.6) 18.1   (25.1) 
                      Retired 7.7  (12.5) 16.7   (23.0) 
 
 
Table 4.4.3. Pain scores in relation to patient characteristics. Values are mean (s.d). 
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 At rest On moving 
No pain     (0) 50     (24.5%) 44     (21.6%) 
Mild          (< 10) 128   (62.7%) 114   (55.9%) 
Moderate  (10-50) 22     (10.8%) 41     (20.1%) 
Severe      (> 50) 4       (2.0%) 5       (2.5%) 
 
 
Table 4.4.4. Severity of pain 1 year after hernia repair in 204 patients. Data given is number 
of patients (% of total). 
 
 
 Number of 
patients 
At rest On moving 
All patients 
                                                
204 
 
Preoperative score at rest 
   0 
  >10 
 
40 
37 
-2.9      (1.2)* 
 
 
  1.8     (0.3)* 
-22.8    (3.7)* 
-9.2     (1.8)* 
 
 
-0.3       (1.6) 
-32.2     (4.8)* 
  
 
Table 4.4.5. Effect of operation on postoperative pain score. Values are mean (s.e.m.). 
                    *P < 0.01 versus baseline value (t- test). 
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Chapter 5:  Impact of light or heavyweight mesh on chronic pain after 
inguinal hernia repair. 
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 5.1. Introduction 
Severe chronic pain is one of the most serious long-term problems that can occur following 
inguinal hernia repair. Population based studies and randomised clinical trials indicate that 
around 30% of patients have some form of pain, while 3% have severe pain at one year 
following hernia repair 144, 192. The reason for such pain is not clear. There may be 
intraoperative factors that contribute to this pain, such as nerve and/ or tissue injury and the 
use of the biomaterials. In the latter context a recent study has indicated that the type of 
material, rigid versus smooth may affect postoperative pain and recovery after laparoscopic 
inguinal hernia repair 193. There is also some evidence from trials of abdominal wall closure 
that absorbable suture materials cause less chronic pain when compared with non-absorbable 
ones 194, 195. 
 
The aim of this study was to compare a partially absorbable, lightweight mesh with a non-
absorbable, heavyweight mesh within the context of a randomised clinical trial. The primary 
endpoint of the study was the degree of chronic pain of any severity at the site of hernia 
repair in both groups at 12 months. 
 
5.2. Patients and Methods 
Ethical approval was obtained in 5 surgical units to randomise patients with an inguinal 
hernia to repair with a light or heavy weight mesh, using the Lichtenstein technique. 
Computer generated random numbers with block sizes to ensure balanced recruitment within 
each centre, achieved randomisation. Patients were 18 years or older and were excluded if the 
hernia was strangulated or irreducible or if they had previously undergone open tension free 
mesh repair on the same side. The study was observer and patient blinded i.e. the member of 
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staff conducting the postoperative assessment and the patients were unaware of the treatment 
allocation. 
 
5.3. Mesh types 
The lightweight or partially absorbable (PA) mesh (Figure 5.1.) used in this study was 
constructed of multifilament of polyprolene with additional absorbable polyglactin (Vypro 
11, Ethicon). The mesh had a pore size of 4mm and weighs 82g/m at implantation and 32g/m 
after absorption of the polyglactin component, which usually takes 56-70 days. The 
heavyweight or non absorbable (NA) mesh (Figure 5.2.) used in the study had a pore size of 
1mm and weighs 85g/m (Atrium). 
 
 
 
 
 
 
 81
  
 
 
Figure 5.1. (PA) Light weight (Vypro 11)  
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Figure 5.2. (NA) Prolene (Atrium) mesh  
 
 
 
 
 83
Preoperatively all patients had visual analogue pain scores (VAS) measured at rest and on 
moving and all patients completed a SF-36 questionnaire (appendix 4). At operation patients 
underwent a standard open tension free mesh repair (Lichtenstein technique) with a detailed 
record of hernia type and size, whether the nerves were identified and preserved or divided, 
and any adverse operative event that may have occurred. All postoperative complications 
were recorded and patients were telephoned with set questions at 10, 20 and 30 days 
postoperatively to assess wound related infection and/or any other wound problems. Those 
that reported a wound infection or haematoma were recalled and examined clinically. 
Hospital stay and time to return to work and normal activities were also recorded for all 
patients. Patients were sent a VAS pain scale at 1, 3 and 12 months and a modified SF-36 
questionnaire. The modifications included questions on pain of any severity at the site of 
hernia repair (none, very mild, mild severe or very severe). Patients were also asked if the 
pain was present all of the time, some of the time, a little of the time or none of the time. In 
addition they all underwent a detailed clinical examination at 12 months looking for any 
evidence of chronic wound problems, testicular atrophy or development of a recurrent or 
contra-lateral hernia. Patients were also asked about any pain or numbness at the site of their 
hernia repair.  If they answered in the affirmative a record of the site and distribution of both 
was mapped out on a diagram. 
 
5.4. Statistical analysis 
The study needed to enrol 300 patients as this was the sample size calculated to ensure an 
80% power to detect a benefit to PA mesh of 15% for primary efficacy  ( incidence of chronic 
pain at 12 months: NA mesh 35%; PA mesh 20% ) at 5% significance using a two-sided test.  
Data have been summarised using both the number and percentage in each category, or by 
using the mean and standard deviation when data are normally distributed, or by using the 
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median and inter-quartile range when data are not normally distributed. An intent-to-treat 
analysis has been performed, i.e., all subjects regardless of their compliance with the 
protocol, were included in the analysis. For efficacy analyses, patients with missing data for 
an assessment have been analysed using the last valid observation carried forward.  
 
All statistical tests were interpreted at the 5% significance level (two-tailed) and 95% 
confidence intervals have been presented. For primary efficacy these are one-tailed, for all 
other parameters they are two-tailed. No adjustments for multiple testing have been 
performed.  
 
5.5. Results 
333 patients consented to participate in the study. Two patients were not randomised as they 
had a femoral hernia and 1 patient withdrew consent prior to surgery. Therefore 330 patients 
were randomised to surgical repair with either PA or NA mesh. Following randomisation 9 
patients either withdrew consent or failed to complete their post-operative assessment. This 
left 162 patients in the PA group and 159 patients in the NA group. The patients in both 
groups were similar with respect to all pre and intra-operative parameters measured (Tables 
5.5.1 and 5.5.2.). All patients had a primary hernia apart from 6 in the PA and 2 in the NA 
group. All these had previously undergone a sutured, non-mesh repair. The ilioinguinal nerve 
was identified in over 90% of patients while the genital branch of the genitofemoral nerve 
and the iliohypogastric nerves were identified in less than 50% of patients. Postoperative 
complications were similar in both groups with 6 wound infections in the PA group (3.7%) 
and 10 (6.3%) in the NA group. 
  
The percentage of patients with pain, as assessed by visual analogue scores at 1 and 3 months 
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postoperatively, did not demonstrate any difference between the groups (Table 5.5.3. and 
5.5.4). Return to normal activities was similar in both groups, taking around 10 days to return 
to social activities and 3 weeks to return to paid employment (Table 5.5.5.). 
 
5.5.1. Pain at 12 months post hernia repair  
Significantly fewer patients in the PA group, 39.5% versus 51.6% in the NA group, 
experienced pain of any severity at 12 months (difference – 12.1%; 95% CI –23%, to –1%; 
p=0.033). The primary end point was analysed by carrying the last observation forward and 
recording pain for those with a missing response as agreed per protocol in both groups. This 
diluted the treatment effect which otherwise was 45 (33.3%) of 135 in the PA group 
compared to 64 (51.2%) of 125 in the NA group (p=0.004). Analysis adjusting for divided 
nerves did not alter the treatment effect. Interestingly the increase in pain in the NA group 
was not associated with any effect on physical function. The reason for this is likely to be 
related to the fact that most patients in both groups had mild or very mild pain. Only 3% of 
patients in the PA group experienced severe or very severe pain at 12 months compared to 
4% in the NA group. Testicular pain was also reported more frequently in the NA group 
(22.1% versus 16.3%). The descriptor of pain most commonly used for all patients was 
aching (64%). In patients with pain, social activity was affected in 13%, work in 22% and 
sexual activity in 33%. Numbness around the groin was reported in 34% of patients and thigh 
numbness was reported in 13.5% of patients at 12 months. This however only affected quality 
of life in 4.5% of patients. 
 
5.5.2. Clinical outcome at 12 months  
142 patients in both groups were examined clinically at 12 months, 3 patients died from 
neoplastic disease while 34 were lost to follow up. These clinical examination findings are 
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illustrated in Table 5.5.6. In the intent to treat population, hernia recurrence was observed 
more often in the PA group, 8 out of 162 (4.9%) versus 1 of 159 (0.6%), p=0.037. This was 
evident following repair of both direct (5) and indirect (3) hernias. Recurrence did not appear 
to be related to the size of the defect as measured at operation. Most of the recurrences in the 
PA group (5) were associated with one particular centre. The median time to recurrence was 
261.5 days with a range of 163 to 339 days. 
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 PA group n=162 NA group n =159 
Age in years 
Male 
BMI 
55.7 (16.4) 
156 (96%) 
25.5 (3.4) 
57.3 (15.8) 
154 (97%) 
25.7 (3.0) 
 
Site of hernia 
Right 
Left 
 
 
 
80 (49.4%) 
82 (50.6%) 
 
 
86 (54.1%) 
73 (45.9%) 
 
 
 
 
 
 
 
 
 
 
Type of defect 
Direct 
Indirect 
Combined 
 
 
64 (39.5%) 
77 (47.5%) 
21 (13.0%) 
 
 
51 (32.1%) 
78 (49.1%) 
30 (18.9%) 
Size of defect 
<1.5cm 
1.5 – 3 cm 
>3cm 
 
 
27 (16.7%) 
74  (45.7%) 
61 (37.7%) 
 
 
24 (15.1%) 
68 (42.8%) 
65 (40.9%) 
 
 
 
 
 
 
 
 
 
 
 
Table 5.5.1. Patient and hernia characteristics (Values are mean (s.d.)) 
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  PA group n=162 NA group n=159 
Type of anaesthesia 
General  
Local  
Epidural 
Spinal 
           
90          (55.6%) 
64          (39.5%) 
0  
8            (4.9%) 
 
94        (59.1%) 
62        (39.0%) 
0 
3          (1.9%) 
Operation time (minutes) 42.50     (17.2*)  42.86   (16.6*) 
Incision length (centimetres) 7.44       (1.9*) 7.42     (1.5*) 
Identified nerves 
Ilioinguinal 
Genital 
Iliohypogastric 
 
145        (89.5%) 
74          (45.7%) 
68          (42.0%) 
 
146      (91.8%) 
77        (48.4%) 
67         (42.8%) 
Divided Nerves 
Ilioinguinal 
Genital 
Iliohypogastric 
 
32        (19.8%) 
13         (8.0%) 
10         (6.2%) 
 
32       (20.1%) 
16       (10.1%) 
11        (6.9%) 
 
Table 5.5.2. Anaesthetic and operative details, * values are mean (s.d). 
 
 
 
 
 89
 PA group n=162 NA group n=159 Difference (95% CI)  
p-value (Fishers exact test) 
Pain @ 1 month 
Yes 
No 
 
133 (82.1%) 
29   (17.9%) 
 
130 (81.8%) 
29   (18.2%) 
 
0.3% (-8% to 9%) 
P = 1.0 
Pain @ 3 months 
Yes 
No 
 
92  (56.8%) 
70  (43.2%) 
 
90  (56.6%) 
69  (43.4%) 
 
0.2% (-11% to 11%) 
P = 1.0 
 
 
Table 5.5.3. Pain at 1 and 3 months. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 90
 VAS pain score 
 
PA group 
( n =162) 
Mean (SD) 
NA  group 
( n = 159) 
Mean (SD) 
P- value * 
 
At rest 
Pre-operative 
1 month 
3 months 
 
10.10 (17.10) 
8.34   (12.03) 
5.19   (11.44) 
 
10.27  (16.36) 
9.67   (16.86) 
6.63   (16.74) 
 
 
0.4 
0.9 
When moving 
Pre -operative 
1 month 
3 months 
 
17.13 (22.36) 
13.37 (16.68) 
8.15   (15.07) 
 
17.92  (21.56) 
14.75  (20.47) 
8.69    (17.31) 
 
 
0.9 
0.9 
 
 
Table 5.5.4. Visual Analogue Pain Scores (VAS) at 1 and 3 months. The statistical test used 
was the Mann-Whitney U *. 
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 PA group NA group P-value 
(Log-rank 
test) 
Paid work 
Looking after house 
Social Life 
Sex 
Hobbies 
21 (14-42) n=82 
10 (5-24) n=161 
10 (5-21) n=161 
28 (14-365) n=161 
20 (10-40) n=161 
26 (10-49) n=77 
10 (4-21) n=154 
14 (7-24) n=154 
28 (14-365) n=154 
14 (7-31) n=154 
0.4 
0.6 
0.6 
0.6 
0.3 
 
 
 
Table 5.5.5. Return to normal activities (days). Values given are medians (inter-quartile 
range). 
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 PA group 
(n=162) 
NA group 
(n=159) 
P –value 
(Fisher’s exact 
test) 
 
*Recurrence 
Contralateral hernia 
Testicular atrophy 
Wound sinus 
 
8 (5.6%) 
2 (1.4%) 
2 (1.4%) 
0 (0%) 
 
1(0.7%) 
4 (2.8%) 
0 (0%) 
0 (0%) 
 
0.037 
0.684 
0.246 
- 
 
 
 
Table 5.5.6. Clinical outcome at 12 months. * Analysis performed with respect to numbers 
who completed postoperative assessment. 
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Chapter 6:  Discussion 
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 Summary of findings of the three trials. 
 
6.1.1. Trial 1 
Chronic pain persists in most patients who report severe or very severe pain at three months 
after hernia repair and has a significant effect on patients’ daily activities and quality of life. 
Of those with chronic severe pain at 3 months, 71% did not report severe or very severe pain 
at 2 ½ years follow up. Only 26% had severe or very severe pain, 45% claimed mild or very 
mild pain and 29% had no pain at all at 2 ½ years follow up. Most patients therefore, will 
report a reduction in severity of pain with time.   
A secondary conclusion is that persistent pain is an indication of other chronic severe pain 
conditions.  
 
 
6.1.2. Trial 2 
The main conclusion from the second trial is that most people with preoperative pain 
attributable to their inguinal hernia will have a reduction in this pain following surgical 
repair. Some patients with little or no pain from their hernia are made worse by surgery. 
 
 
6.1.3. Trial 3 
This study explores the concept that reducing the amount of mesh left in situ after inguinal 
hernia repair does not reduce long term pain. Partially absorbable meshes need to be handled 
differently to non absorbable meshes.  
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 Significance of findings 
In the first study we found that severe or very severe pain was reported in 3% of patients at 3 
months after groin hernia repair in Scotland. At an average follow up of two and half years 
later 25% still reported severe or very severe pain. This had profound effects on daily 
activities and quality of life. Only 29% of the group reported no pain while in 45% the pain 
had become mild or very mild. Almost half of these patients had sought treatment for their 
pain by visiting their GP, surgeon or pain clinic.  
 
This is the second study that has examined chronic pain after hernia repair on a nationwide 
basis. In the initial Danish study looking at 1,652 patients operated on for a groin hernia over 
a two month period,  28.7% reported pain at one year after surgery 144. Although 11% 
reported the pain to affect leisure activities only 4.5% sought or received medical treatment 
while 3% reported the pain to be moderate or severe 144. In the Medical Research Council 
randomised trial of laparoscopic versus open groin hernia repair, 28.7% of laparoscopic and 
36.7% of open patients had groin pain at one year 3. The respective figures for severe or very 
severe pain were 3.8 and 2.2 %. In a subset of 379 patients operated on under the care of one 
surgeon from the same study and followed clinically for a median of five years, 6 (1.6%) 
required referral to a pain clinic for management of severe or very severe pain. In 3 of these 
patients the pain resolved while 2 still had mild pain and 1 died from bronchogenic cancer.  
 
This is the first population-based study to determine what happens to patients reporting 
severe or very severe pain after repair of a groin hernia over a period of time. As with a 
previous study, the indications are that post repair pain resolves or becomes mild or very mild 
in the majority of patients. However, around 25% continue to have severe or very severe 
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pain. This is similar to that reported in a retrospective study where 30% of those with pain at 
three months after operation reported moderate or unbearable pain at a median follow-up of 
43 months 136.  
 
The aetiology of chronic groin pain post hernia repair is related in part to nerve injury. This is 
supported by the high frequency of sensory symptoms and numbness in these patients. 
However other factors including the role of tissue injury need to be considered. The character 
and distribution pattern of pain suffered by these patients is similar to that observed in 
athletes in groin injury where the source of pain is thought to be muscular or ligamentous 
injury. A third factor that needs to be considered includes the role of non-absorbable material 
be it sutures or mesh. While there have been no comparative studies in hernia repair, use of 
absorbable suture materials have consistently been shown to cause less chronic pain after 
abdominal wall closure when compared with non absorbable materials. The individual 
perception of pain is also important. Patients who develop chronic pain post inguinal hernia 
repair are more likely to have complained of pain preoperatively from their hernia when 
compared to those who have no postoperative pain. In addition our study indicates that they 
are more likely to suffer other chronic pain conditions when compared with the normal 
population. In population-based studies 27-39% of patients surveyed indicated they had back 
pain in the last week or month, the respective figures for patients with very mild or mild pain 
and severe or very severe pain in this study are 45.7% and 77.3%. An alternative explanation 
for the high incidence of back pain in those patients with severe pain following groin hernia 
repair is that this group of people may be related to placing excessive strain on their back 
muscles in an effort to protect their groin. Further studies on the interrelationship between 
chronic pain conditions in general and the psychological profile of these patients are required. 
The current study may underestimate the frequency of severe or very severe pain following 
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hernia repair in that some patients may develop this problem after the first questionnaire was 
sent out. However in a study by Callesen et al moderate or severe pain at four weeks was a 
significant predictor of the same type of pain at one year 141. Therefore better or more 
effective postoperative pain control in the acute period following surgical repair is necessary 
to reduce risk of long term severe chronic pain. Despite this around one half of the patients 
that had moderate or severe pain at one year had none or mild pain at four weeks following 
surgery in their study. In a similar study where we followed 379 patients for a median of five 
years after groin hernia repair, 25% of patients that had chronic pain developed their pain 
after the one year follow up period. Most, however we found were concerned that their repair 
had broken down and when reassured that this was not the case their symptoms resolved. 
Over 2/3 of patients that complain of severe or very severe chronic pain at three months after 
groin hernia repair still have pain two – three years later. While the mechanism of this pain is 
unclear counselling patients on its probability before surgery is important. Early referral to an 
established pain clinic should be considered for those who develop this debilitating problem.  
 
The second study demonstrates that most primary inguinal hernias repaired electively are 
painless or cause the patient only mild pain. The decision to classify mild pain as a score of 
less than 10 in this study was arbitrary and is lower than that suggested by some workers 17. 
The findings that almost 60% of patients indicated that the hernia was painless or caused mild 
pain only on movement, while 80% had no pain or mild pain at rest are, therefore 
conservative. This remains so even if acute inguinal hernias causing severe pain are included, 
as they account for only 5% of all inguinal hernias treated in the region 1.  At one year follow 
up, patients who had no pain at rest from the hernia before the operation reported significant 
pain scores from the hernia repair site. Although these scores were low the finding goes some 
way to explaining the relatively low level of satisfaction reported by some patients following 
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hernia repair 3. When asked about change in day-to-day life 1 year after hernia repair in one 
study, almost 30% of patients reported no change while 5% were slightly or much worse after 
surgery 3.   A further 12% reported that hernia repair made day-to-day life only slightly 
better, and 55% were much better. The presence of pain in patients who were asymptomatic 
from the hernia in the first place is worrying and leads one to question whether these patients 
should have had a hernia repair in the first instance. It may therefore be suggested that some 
patients, typically those that have no symptoms attributable to their hernia are made worse by 
surgery. The most common reason for recommending patients for repair is the risk of 
strangulation or incarceration. However it is known that the probability of the latter occurring 
is rare and is observed in only one in every 300-400 patients 151. The cumulative risk of 
strangulation of an inguinal hernia at three months is 2.8% increasing to 4.5% after 2 years 
152.  Moreover patients who develop an acute hernia accident may not be aware that they have 
a hernia and if so have sufficient co-morbidities that they are turned down for elective repair 
196. There was no association in this study between hernia type, direct or indirect or the 
patients’ occupation sedentary or manual labour, and pain at the hernia site. Conventionally it 
has been thought that indirect hernias are more likely to be symptomatic and that a hernia in 
someone who does heavy manual labour may be an inconvenience. Indeed one may be 
persuaded that this patient group may be more likely to register high pain scores on moving. 
We did not find this to be the case. Indeed the trend in this study was for these patients to 
have the lowest pain scores at rest and on moving. Results from this study indicate that hernia 
repair has less effect than might be expected on the mild pain caused by the hernia. Pain 
scores at rest and moving were reduced to only about half the level before operation. 
Furthermore it is disappointing that there was not a significant increase in the number of 
patients who recorded no pain at rest or on movement at one year after the operation.  
The major effect of hernia repair as seen in this study appears to be to convert those with 
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moderate or severe pain on moving to mild pain on moving. One of the drawbacks of this 
present study is that other quality of life issues such as the effect of a hernia on social or 
sexual activity has not been examined here. In a previous study 151, however we have shown 
that leisure activities were affected in only 29% of patients with an inguinal hernia, while 
only 13% had to take time off work because of the hernia. Further studies are needed in this 
area to look at these factors in more detail, particularly in those patients who report little or 
no symptoms from their inguinal hernia.   
 
This study demonstrated that those patients that had most in the way of symptoms from their 
hernia, i.e. moderate to severe pain on moving and at rest, were most helped by surgery, i.e. 
their symptoms were improved. In contrast it is clear that some patients are made worse by 
surgery, i.e. those with little or no symptoms. Therefore further studies are necessary to 
precisely define the population group with an inguinal hernia that will most benefit from 
surgery with the least risk of postoperative pain 138, 139. 
 
The final study shows that there is no difference in pain scores at rest and on movement 
between patients randomised to a (PA) partially absorbable or (NA) non absorbable mesh. 
There was also no difference in severe pain between these two groups. It is likely that the 
small differences in all types of pain reported in favour of the PA group reflected differences 
in mild and very mild pain in this study. This finding is in keeping with other studies where 
patients were less likely to feel a foreign body in their groin after inguinal hernia repair with 
Vypro mesh 197 . This study compared a composite lightweight mesh (Vypro) developed for 
incisional hernia repair, with a heavy weight polyprolene 100-110g/m mesh in inguinal 
hernia patients. Patients in the Vypro group had less pain on exercise and were less likely to 
report the feeling of a foreign body at 6 months. This study included bilateral hernias where a 
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different type of mesh was placed on either side and the primary outcome measure was the 
feeling of a foreign body at six months. One previous study has compared a rigid and smooth 
heavy weight polypropylene mesh following laparoscopic inguinal hernia repair in a 
randomised clinical trial 193.  In that study patients had less pain and better physical function 
during the early recovery period with the smooth mesh. The study was however 
underpowered with only 20 patients in each group. In addition pain scores were high and 
return to work and normal activities was longer than one might expect after laparoscopic 
hernia repair. 
Severe chronic pain is a serious long-term problem that occurs after inguinal hernia repair. It 
has a significant negative impact on quality of life and ability to work. These effects are 
associated with significant healthcare costs and can persist for several years. Experimental 
studies indicate that the addition of polyglactin filaments to a lighter weight polypropylene 
mesh reduces the inflammatory reaction and formation of fibrous tissue. In addition it causes 
less restriction of abdominal wall movement when compared with heavy weight meshes. 
These findings are not consistent with the clinical results of the current study in that the 
patients with the lightweight mesh do not have significantly less pain at 12 months. Based on 
the law of La Place and maximal intra-abdominal pressures, Klinge and colleagues have 
calculated that a mesh with a tensile strength of 16N cm is sufficiently strong to use in repair 
of abdominal wall hernias 198.  This is thought to represent the physiological strength of the 
human abdominal wall and is significantly lower than that of most meshes. Experimental 
studies with the composite polyglactin and polypropylene as used in the current study show 
that the tensile strength at the suture fascia mesh interface is in fact in excess of 16N.  
One of the disappointing results of this study was a significant increase in recurrence rates in 
the partially absorbable group. Subsequent investigation revealed that the reason for this was 
that the suture pull out force in the knitted direction of the mesh was low. This may have 
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caused or contributed to the high recurrence rate in the partially absorbable group. The 
manufacturers had stressed that suture bites of least 1cm were required with their product. 
Surgeons used to taking smaller bites of mesh as is routine with conventional polypropylene 
mesh, underestimated the consequence of inadequate fixation with Vypro 11. This may 
explain why most of the recurrences, 5 of 8, were observed in one particular centre. Surgeons 
in this centre admitted that they did not adhere to taking suture bites of at least 1cm with the 
PA product. 
The PA mesh used in this study was among the first of its type to be investigated in a 
randomised clinical trial. The perceived advantage of leaving about one third of the amount 
of polypropylene in situ after the polyglactin component is absorbed has been exploited in 
other products which maintain the tensile strength of the absorbable component for a longer 
period (e.g. Ultrapro 199). These products may perform better than Vypro 11 but require to be 
evaluated in a similar fashion. The manufacture of meshes with less polypropylene and larger 
pore size, 3-4mm, should also be evaluated in randomised clinical trials. The in-vitro 
performance of these products may not be matched by what happens in patients. New 
products such as polyvinylidenfluoride which have a similar weight to conventional 
polypropylene meshes but a larger pore size also require further careful evaluation in long 
term follow up studies 200. Biological products which are thought to help stimulate ingrowth 
of normal human blood vessels and collagen have also had limited testing in inguinal hernia 
repair 201 . 
 
One of the drawbacks of the many new products is the increased costs. Some of these 
products are several times more expensive than conventional polypropylene meshes. It 
follows therefore that a dramatic improvement in quality of life to the patients with similar or 
reduced recurrence rates would be required to justify their routine use in inguinal hernia 
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repair. While this seems unlikely, cost to the health service of a product would reduce if 
proven advantages resulted in increased use. 
 
This study does not supports the concept that reducing the amount of mesh left in-situ after 
inguinal hernia repair reduces long-term pain. The increase in hernia recurrence in the PA 
mesh group warrants further research. This can be explained as a technical error, i.e. not seen 
if appropriate suture bites of the mesh are taken rather than a specific defect inherent in the 
mesh itself. We have found that the Vypro mesh must be handled differently to the standard 
prolene mesh. For optimum results it must be sutured with a 1cm flap to the ilioinguinal 
ligament and it cannot be placed on the stretch.  
These results are similar to a study by Bringman et al 202. These authors’ randomised six 
hundred men to open Lichtenstein repair with a prolene or a Vypro 11 mesh in several 
different centres. Pain, recurrence and quality of life were assessed at one year post surgery. 
They found no statistical difference in each of the previous parameters. They concluded that 
the results of Lichtenstein’s operation with either prolene or Vypro 11 mesh did not seem to 
differ significantly. Their results at three years were a little different. They found that use of 
the light weight mesh had improved some aspects of pain and discomfort at three years post 
repair 203.  
This study demonstrates no clinical advantage for the use of a partially absorbable mesh in 
inguinal hernia repair. The significant reduction in mild discomfort observed warrants further 
investigation with different products in larger multi centred controlled clinical trials. 
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Further research  
The conclusions of the previous trials raise further points for discussion and future research. 
In order to reduce the incidence of post herniorrhaphy pain, future research needs to address 
the patient with an inguinal hernia at several stages.   
 
In order to quantify how much postoperative pain is truly related to post surgical changes, it 
is important to be aware of the incidence of groin pain per se, in the general population. What 
extent of pain experienced postoperatively by our patients is truly related to the hernia repair 
and what amount is indigenous or related to other factors? for example, osteoarthritis of the 
hip, prostate pathology. The significance of these other pathologies in contributing to 
postoperative pain is not widely known.  These other causes of groin pain are known to 
increase in prevalence in the aged male population and need to be excluded.   Symptoms 
attributable to a groin hernia by the patient may not actually be related to the groin lump and 
therefore it is these symptoms that will continue post repair, resulting in pain.  
 
 In a recent study by Franneby et al 211 long term postoperative pain was assessed. They 
found a baseline level of pain in the contralateral groin, but the level of pain was significantly 
higher in the operated groin. The contralateral groin was used as a control and it is important 
to note that it was not pain free. The baseline level of pain in the non operated non hernia side 
served as a reference point.  Future studies should include assessment of baseline levels of 
pain not only in the preoperative groin but also in the contralateral side.  
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Studies that try to quantify a subjective emotion have faults and one of these is that the tools 
used to accrue information are too precise. What is the clinical significance of 5mm of pain 
difference on the visual analogue scale? We assume that if a difference is statistically 
detectable then it is clinically significant. This may not be the case. The scales we employ to 
detect change may be too powerful. That is they detect differences where none actually exist 
clinically.  
 
Another concern of the pain scales is their reproducibility.  Do scoring systems have the same 
numerical outcome when repeated several times over the same day by the same individual?  
These tools account for patient personality. That is, those with a propensity to exaggerate or 
remain stoical will continue to do so irrespective of how often the test is performed.  These 
tests may not, however allow for intention tremors and other features of the elderly 
population that make precision tasks more difficult. This may or may not explain why older 
people complain of less postoperative pain. It is not clear why  younger people, who are more 
inclined to be in work, be independent or self employed complain of more pain than their 
elder counterparts.    
 
In those that have pain more precise psychological information is needed, for example, 
features of depression. Preoperative assessment of psychological state or traits can help in the 
understanding of the subjective postoperative emotion of pain.  
The expectations of patients attending a surgical outpatient clinic with an inguinal hernia 
need to be better understood. Is reassurance of the benign nature of the lump all that patients 
wish or do they expect a surgical solution from the outset? Is it that those on the waiting list 
become more symptomatic the longer they wait? And if so, is this a reflection of the 
underlying pathology of the hernia or is it because their initial expectations of surgery are not 
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being met? When patients are placed on the waiting list for surgical repair the degree and 
type of pain should be assessed over time waiting for repair. 
The fact that many men have minimal if any symptoms attributable to their hernia led 
Fitzgibbons et al 138 to design a multicentred, randomised controlled trial to determine if 
watchful waiting was an acceptable alternative to surgical intervention in  patients with 
minimal or no symptoms from their hernia. Over 750 patients were enrolled to either standard 
Lichtenstein tension free open mesh repair or to watchful waiting for a period of 2 years. The 
end points at two years were symptoms including pain. They concluded that watchful waiting 
was an acceptable alternative for patients with minimally symptomatic hernias 212. Delaying 
surgery until symptoms increase is safe as acute accidents occur rarely, they conclude. 
However in a similar study by O’Dwyer et al 139 surgery was compared with wait and see 
policy in asymptomatic hernia patients. In 160 patients, aged 55 years or older the authors 
were surprised at the high number of patients crossing over from watchful waiting to surgical 
intervention because of an increase in symptoms. Postoperative pain and symptoms were no 
different in either group at 12 months post surgery. They concluded that repair of an 
asymptomatic hernia does not affect the long term incidence of chronic pain and may be 
beneficial in improving overall general health. Clearly there is a point that varies with each 
individual that decides benefit of surgical intervention in terms of reduction in symptoms 
with little or no postoperative pain.  
   
Most of our studies are relatively short term. It would be worthwhile to follow patients for 
longer in order to see what happens to those initially reporting chronic severe pain. If they are 
followed long enough will postoperative pain eventually disappear? What happens to those 
patients with chronic postoperative pain that are referred to the pain clinic?  The average 
general surgeon looses track of their patients once they are referred to the chronic pain 
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speciality. Chronic pain specialists have a better understanding and knowledge of the 
longterm outcome of these patients. Hernia specialists should liaise closely with chronic pain 
specialists in order to fully appreciate the longterm outcome of these patients.  
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 APPENDIX 1  
 QUESTIONNAIRE (MODIFICATION OF SF36 ) 
 
1. During the last week how much of the time have you had pain in your groin (the site of the 
hernia operation) 
All of the time                               
Most of the time 
Some of the time 
A little of the time 
None of the time 
 
 
2. How bad has the pain in your groin (the site of the hernia operation ) been in the past 
week? 
No pain 
Very mild 
Mild 
Severe 
Very severe 
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3. Have you experienced any numbness in your groin (the site of your hernia operation) in the 
last week? 
Not at all 
Slightly 
Moderately 
Quite a bit 
Extremely 
 
 
 
 
4. Have you experienced any numbness down your thigh on the side of your hernia operation 
in the last week? 
Not at all 
Slightly 
Moderately 
Quite a bit 
Extremely 
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5. Have you experienced any pain in your testis on the side of your hernia operation in the 
last week? 
All of the time 
Most of the time 
Some of the time 
A little of the time 
None of the time 
 
 
 
 
6. Is the pain you experience  
Intermittent 
Continuous 
Present at rest 
Brought on by activity 
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                                                      APPENDIX 2  
                                 QUESTIONNAIRE (BPI ) AND ABOVE 
 
1. Please tick the box number that best describes how, during the past 24 hours PAIN has 
interfered with your; 
 
Does not                                                                                                               Completely 
Interfere                                                                                                                 Interferes 
A.General Activity                                                                                                                                               
0 1 2 3 4 5 6 7 8 9 10 
                                                                                                                    
                                   
B. Mood 
0 1 2 3 4 5 6 7 8 9 10 
 
 
C. Walking Ability 
0 1 2 3 4 5 6 7 8 9 10 
 
 
D. Normal Work (including work outside the home and housework) 
0 1 2 3 4 5 6 7 8 9 10 
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E. Relations with other people 
0 1 2 3 4 5 6 7 8 9 10 
 
F. Sleep 
0 1 2 3 4 5 6 7 8 9 10 
 
 
G. Enjoyment of life 
0 1 2 3 4 5 6 7 8 9 10 
 
 
 
 
2.  What words best describe your pain? 
 
     Aching                                               Prickling 
     Burning                                              Pulling 
     Cutting                                               Shooting 
     Drilling                                              Sickening 
     Electric                                              Stabbing 
     Gnawing                                            Tender 
     Itching                                               Throbbing 
     Pounding                                           Tingling 
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3. Have you been to the GP with your pain?               Yes          No 
   Have you been to your surgeon with the pain?         Yes          No 
   Have you been to a pain clinic with your pain?        Yes          No 
   Have you had another operation on your hernia?     Yes          No 
 
 
 
 
4. Are you taking any medication for pain relief? 
    If Yes, please specify       name                                      dosage 
 
 
 
 
5. Do you or have you suffered from other chronic problems, such as 
      Backache                         yes        no 
     Headache                          yes        no 
     Irritable Bowel                 yes        no 
     Other (please specify)       yes        no 
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                                                                 APPENDIX 3                             
    (VISUAL ANALOGUE PAIN SCALES) 
 
1. Please put a vertical (straight up and down) line through the scale from 0 to 100 
corresponding to how much pain you have from your groin (the site of the hernia operation) 
TODAY.  
The scale goes from 0 (no pain) to 100 (worst pain imaginable). 
 
On the scale below please mark the amount of pain you have at REST today 
 
 
0    ……………………………………………………………………………….100                                          
No pain                                                                                                               Worst pain   
                                                                                                                            imaginable 
 
 
 
2. On the scale below, please mark the amount of pain you have on MOVING today. 
0………………………………………………………………………………………100                                   
No pain                                                                                                          Worst pain 
                                                                                                                        Imaginable 
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                                             APPENDIX 4  
 
STUDY FLOW CHART 
 
 IN-PATIENT 
VISIT 1 
TELEPHONE 
ASSESSMENT 
DAYS 10, 20 
AND 30 
POSTAL 
ASSESSMENT 
1, 3 AND 12 
MONTHS 
CLINIC VISIT 
2 @ 12 
MONTHS 
Inclusion/exclusion X    
Demographics X    
Medical history X    
Prior/concomitant 
medication 
X   X 
Patient consent X    
SF-36 and  
modified hernia 
questions 
X**  X  
Visual analogue 
scale 
X  X  
Intra-operative 
details/Surgery OT 
form 
X    
Mesh handling 
questionnaire* 
X    
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Adverse events X X X X 
Wound assessment 
telephone 
questionnaire 
 X   
End of study form X X X X 
Annual follow-up 
form 
   X 
 
*Only to be carried out on the first 10 patients per study group per surgeon. 
X** At this time-point ONLY questions 1-10 of the SF36 should be given pre-operatively. 
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SF36 PRE-OPERATIVE QUESTIONNAIRE 
 
GENERAL HEALTH (please circle) 
1. In general would you say your health is 
Excellent (1)          Very Good (2)           Good(3)          Fair(4)           Poor(5) 
 
2. Compared to one year ago, how would you rate your health in general now? 
Much Better (1)       Somewhat Better (2)    About the Same (3)     Somewhat Worse (4)    
Much Worse (5) 
 
HEALTH AND DAILY ACTIVITIES (please circle) 
3. Does your health limit you in any of these activities of a typical day? 
 
 Yes, limited a lot Yes, limited a little No, not limited at all 
Vigorous activities 
(running, lifting 
heavy objects) 
1 2 3 
Moderate activities 
(hovering, golf) 
1 2 3 
Lifting groceries 1 2 3 
Climbing several 
flights of stairs 
1 2 3 
Climbing one flight 
of stairs 
1 2 3 
Bending, kneeling or 1 2 3 
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stooping 
Walking more than a 
mile 
1 2 3 
Walking half a mile 1 2 3 
Walking a 100 yards 1 2 3 
Bathing or dressing  1 2 3 
 
 
 
4. During the past four weeks, have you had any of the following problems with your 
work or other daily activities as a result of your physical health? 
1. Cut down on the time you spend on work or other activities      Yes (1)    No (2) 
2. Accomplished less than you would have liked?                           Yes (1)    No (2) 
3. Were limited in the kind of work or other activities?                   Yes (1)    No (2) 
4. Had difficulty performing the work or other activities?               Yes (1)    No (2) 
 
5. During the past four weeks have you had any of the following problems with your work 
or other regular daily activities as a result of any emotional problems? 
1. Cut down on the amount of time you spend on work or other activities  Yes (1)  No(2) 
2. Accomplished less than you would have liked                                         Yes(1) No (2) 
3. Did not do work or other activities as carefully as usual                         Yes (1)   No(2) 
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6. During the past four weeks, to what extent has your physical health or emotional 
problems interfered with your normal social activities with families, friends or 
neighbours? (please circle) 
 
            Not at all (1)     Slightly (2)   Moderately (3)   Quite a bit (4)   Extremely (5) 
 
 
7.   How much bodily pain have you had over the past four weeks? (please circle) 
 
          None (1)   Very mild (2)    Mild (3)    Moderate (4)     Severe (5)     Very severe (6) 
 
 
8. During the past four weeks how much did pain interfere with your normal work? 
(please circle) 
      Not at all (1)      A little bit (2)      Moderately (3)    Quite a bit(4)          Extremely(5) 
 
 
9. The following questions are about how you feel and how things have been with you 
during the last month, please circle the number that best describes how you have 
been feeling. 
 
 All of the 
time 
Most of the 
time 
A good bit 
of the time 
Some of 
the time 
A little of 
the time 
None of the 
time 
Did you feel full 
of life? 
1 2 3 4 5 6 
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Have you been a 
very nervous 
person? 
1 2 3 4 5 6 
Have you felt so 
down in the 
dumps that 
nothing could 
cheer you up? 
1 2 3 4 5 6 
Have you felt 
calm and 
peaceful? 
1 2 3 4 5 6 
Did you have a 
lot of energy? 
1 2 3 4 5 6 
Have you felt 
downhearted and 
low? 
1 2 3 4 5 6 
Did you feel 
worn out? 
1 2 3 4 5 6 
Have you been a 
happy person? 
1 2 3 4 5 6 
Did you feel 
tired? 
1 2 3 4 5 6 
Has your health 
limited your 
social activities? 
1 2 3 4 5 6 
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 HEALTH IN GENERAL 
 
10. Please choose the answer that best describes how true or false each of the following 
statements is for you 
 
1. I seem to get ill more easily than other people 
Definitely true (1)  Mostly true (2)   Not sure (3) Mostly false (4) Definitely false (5) 
 
2. I am as healthy as anyone I know 
     Definitely true (1)  Mostly true (2)  Not sure (3)  Mostly false (4)  Definitely false (5) 
 
3. I expect my health to get worse 
           Definitely true (1)  Mostly true (2)  Not sure (3)  Mostly false (4)  Definitely false (5) 
 
4. My health is excellent 
Definitely true (1)  Mostly true (2)  Not sure (3)  Mostly false (4)  Definitely false (5) 
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VISUAL ANALOGUE SCALE (VAS) 
Please put a vertical (straight up and down) line through the scale from 0-100 
corresponding to how much pain you have from your hernia TODAY. The scale goes 
from 0 (no pain) to 100 (worst pain imaginable). 
 
1. On the scale please mark the amount of pain you have at REST today 
 
0                                                                                                                                             100    
 
 
 
2. On the scale below please mark the amount of ON MOVING today pain you have 
 
 
0                                                                                                                                            100  
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   VISIT 1                                           
 
INCLUSION CRITERIA 
1. Primary or recurrent uncomplicated inguinal hernia                          yes         no 
2. Unilateral hernia                                                                                 yes         no 
3. Elective surgery only                                                                          yes         no 
4. Male and female patients                                                                    yes         no 
5. Patients able to comply with follow-up                                              yes         no 
6. Patients willing to give signed consent                                               yes         no 
             
 
 
Informed consent has been signed and dated on   .................................. 
 
 
 
EXCLUSION CRITERIA 
1. Patients in other investigational drug/medical device studies             yes      no 
2. Patients with strangulated, irreducible inguinal hernia                        yes      no 
3. Patients with a previous hernia mesh repair                                        yes       no 
4. Patients under the age of 18 years                                                       yes       no 
  
If the answer to any of these questions is yes the patient is not eligible for the study. 
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DEMOGRAPHIC DATA 
1. Date of birth ………………… 
2. Gender      male           female 
3. Height       …………..m 
4. Weight      ……………Kg 
 
EMPLOYMENT STATUS 
1. Full-time 
2. Part-time 
3. Self-employed 
4. Retired 
5. Not employed 
 
OCCUPATIONAL TYPE: DEFINE LEVEL OF WORK 
1. Largely sedentary work 
2. Predominantly sedentary 
3. Active work 
4. Essentially always on feet 
5. Very labour intensive 
6. Not working/retired 
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HOME ACTIVITIES/HOBBIES 
Activity type: define level of activity during a normal day 
1. Largely sedentary    (Sit down > 75%) 
2. Fairly sedentary       (Sit down 50-75%) 
3.  Moderately active   (Sit down 25-50%) 
4. Very active              (Sit down 10-25%) 
5. Always on feet        (Sit down <10%) 
 
 
RISK FACTORS 
Please review the patient’s medical history and record the presence of any risk factors as 
noted below. 
1. Diabetes mellitus 
2. Chronic obstructive airways disease 
3. Renal insufficiency 
4. Malnutrition (serum albumen <30g/l) 
5. Corticosteroid therapy 
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MEDICAL HISTORY 
Please review the patient’s medical history and record details of any co-existent 
disease. Enter the system code from the list below and provide details in the specific 
illness/disease section. 
1. Endocrine                                               5. Genito-urinary 
2.     Skin                                                      6.  Gastro-intestinal 
            3.    CNS                                                       7.  Cardiovascular 
4.  Respiratory                                               8. Musculoskeletal 
                                                                      9. Other (please specify below) 
 
 
SYSTEM 
(code from options above) 
 
         SPECIFIC ILLNESSES/DISEASE 
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VISIT 1 AND 2. 
PRIOR AND CONCOMITANT MEDICATION. 
 
This list should be added to as the patient progresses through the study. 
Any medication not on the list should be added in the free space at the bottom. 
 
Medication Yes Medication Yes 
 Temazepam  Cephalosporin  
Omnopon  Penicillin  
Atropine  Gentamicin  
Hyoscine  Codeine  
Scopolamine  Paracetamol  
Omnoscop  Cocodamol  
Morphine  Codydramol  
Propofol  Dihydrocodeine  
Suxamethonium  Temgesic  
Atracurium  Metoclopramide  
Pancuronium  Prochlorperazine  
Thiopentone  Cyclizine  
Fentanyl  Domperidone  
Nitrous Oxide  Lactulose  
Halothane  Fybogel  
Enflurane  Senna  
Lignocaine  
                   
Coproxamol  
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 Bupivicaine  Diclofenac  
Diuretics   Ibuprofen  
Ranitidine   Aspirin  
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SURGERY 
POST-OPERATIVE DETAILS 
1. Has there been any untoward bleeding? 
2. Has there been urinary retention requiring catheterisation? 
3. Is there evidence of seroma formation? 
4. Has there been an immediate recurrence of hernia? 
5. Other  
 
Ensure that the Surgery (OT) form has been completed  
Ensure that intra-operative mesh evaluation form has been completed (if appropriate) 
 
 
TO BE COMPLETED ON DAY OF DISCHARGE 
Date of Admission    ............................. 
Date of Surgery        .............................. 
Date of Discharge    ............................... 
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UNSCHEDULED INTERIM VISIT 
WOUND INFECTION 
Each unscheduled interim visit for wound infection only should be documented here 
 
 
FIRST UNSCHEDULED INTERIM APPOINTMENT 
Date of 1st post-discharge clinic attendance              ....................................... 
Is the wound clinically infected?      Yes        No 
If Yes, please complete an adverse event form 
 
SECOND UNSCHEDULED INTERIM APPOINTMENT 
Date of 2nd post-discharge clinic attendance             ........................................ 
Is the wound clinically infected?      Yes        No 
If Yes, please complete an adverse event form 
 
THIRD UNSCHEDULED INTERIM APPOINTMENT 
Date of 3rd post-discharge clinic attendance              .......................................... 
Is the wound clinically infected?       Yes        No 
If Yes, please complete an adverse event form 
 
 
AT FINAL (12 MONTH) VISIT 
There were no clinical wound infections for this patient    Yes      No 
. 
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ADVERSE EVENTS FORM  
 
Adverse 
event 
Onset 
date 
Intensity 
1.Mild 
2.Moderate 
3.Severe 
Serious 
1.Yes 
2. No 
Action 
taken 
1.None 
2.Medical 
3.Surgical 
Outcome 
1.Resolved 
with 
treatment 
2.Resolved 
spontaneously 
3.Ongoing at 
study end 
4.Death 
Stop 
date 
Relationship of 
event to device 
1. Probable 
2. Possible 
3. Unlikely 
4. Not 
related 
 
1.        
2.        
3.        
4.        
 
 
Comments
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VISIT 2 12 MONTHS (OR EARLIER WITHDRAWL) 
 
EVENTS OVER LAST 12 MONTHS RELATED TO HERNIA REPAIR 
1. Surgery for recurrence                                                                       Yes               No 
2. Any surgery related to hernia repair?                                                 Yes              No 
 
SYMPTOMS RELATED TO HERNIA REPAIR 
1. PAIN                                                                                                   Yes             No 
If no complete the visual analogue scale form 
If yes please mark distribution on diagram 
If yes, is the pain .............................................Intermittent                             Yes           No 
                                                                        Continuous                               Yes           No 
                                                                        Present at rest                           Yes           No 
                                                                        Brought on by activity             Yes           No 
 
What word best describes the pain?                       Aching                 Shooting 
                                                                                Throbbing             Electric 
                                                                                Gnawing              Tingling 
                                                                                Burning                 Itching 
                                                                                Stabbing 
 
Does the pain affect any of the following, 
1. Work or daily activities                  Yes       No 
2. Social activities                              Yes       No 
3. Is the patient sexually active?        Yes       No 
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4. If Yes, does the pain affect sexual activity   Yes     No 
 
Mark the amount of pain at rest on the visual analogue pain scale 
Mark the amount of pain on movement on the visual analogue pain scale 
   
2. NUMBNESS                              Yes             No 
If yes mark distribution on diagram  
Does this affect you in any way?           Yes               No 
If yes please expand 
 
 
FINDINGS ON EXAMINATION  
1. Recurrence                           Yes     No 
2. New contra-lateral hernia    Yes     No 
3. Testicular atrophy                Yes     No 
4. Wound sinus                        Yes     No 
5. Allodynia                             Yes     No 
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DIAGRAM TO ILLUSTRATE DISTRIBUTION OF PAIN 
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 DIAGRAM TO ILLUSTRATE DISTRIBUTION OF NUMBNESS 
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VYPRO 11 for inguinal hernia repair 
 
Patient consent form 
 
Have you read and understood the patient information leaflet and what will be 
required of you if you take part?                     Yes      No 
 
 
Have you had an opportunity to ask questions and discuss this study? 
                                                                        Yes     No 
 
 
Have received satisfactory answers to your questions? 
                                                                        Yes     No 
 
 
Do you understand that your participation in the study is voluntary and that you may 
 
withdraw from the study:                                Yes      No 
 
-at any time 
 
- without having to give a reason for withdrawing 
 
- without affecting your future medical care  
 
Do you agree to allow authorised trial personnel to check trial data against your  
 
medical records for accuracy, on the understanding that any personal information will  
 
be treated in the strictest confidence?             Yes       No 
 
 
Do you agree to take part in this study?           Yes       No 
 
Who explained this study to you? 
 
 
Dr/Miss/Mr……………………………………………………………. 
 
 
Patient’s signature…………………………….. Date……………………… 
 
 
Please print name……………………………… 
 
Investigator’s Signature……………………….. 
The patient MUST sign AND date this form PERSONALLY. 
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